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INTRODUCTION 
Sexually transmitted diseases (STDs) have been recognised as a major public 
health problem for a number of years. Regardless to medical advances, STDs 
continue to pose a threat to the health and welfare of individuals. Human 
immunodeficiency virus (HIV) and STDs epidemics are having remarkable 
social, demographic and economic consequences. 
There has been a dramatic increase in the reported STD incidence in East-
Europe and Central Asia. Despite the underreporting of cases and decline in 
mass screening an epidemic has been documented. 
In Estonia the STD incidence rapidly and substantially increased during the 
early 1990s and started to decline after 1994. Regardless to the rapidly and 
substantially increasing STD rates the epidemic of HIV infection was held 
during the decade until year 2000. 
Epidemiology of sexually transmitted diseases concerns the incidence, distri­
bution and trends in STD and related complications. The incidence and distribu­
tion of STDs show considerable variation across space and time, which reflects 
the distribution and trends in their determinants. Factors affecting the transmis­
sion of STDs can be categorised into those acting at the level of individuals 
(e.g. biological and psychological-behavioural) and others at the level of the 
sociophysical environment. The factors of the sociophysical environment asso­
ciated with the community STD rates are economic, geographic, structural, 
technological and sociocultural, as well as the prevalence of disease in the 
population. 
The two main sources of information on the prevalence and incidence of 
STDs are case-notification reports and epidemiological studies. In Estonia, the 
surveillance of HIV infection and STDs is based on the mandatory universal 
notification of newly identified cases to the State Health Protection Service 
(with the same reporting principles in use throughout the period). 
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REVIEW OF THE LITERATURE 
1. Sexually transmitted diseases 
In the last decades there have been considerable development in the field of 
STDs. To a large extent, it has been conditioned by the HIV/AIDS epidemic, 
but also increased recognition of the range and severity of complications and 
sequelae that can be linked to these infections, and development of new case-
management approaches should be noted. More than 30 bacterial, viral, and 
parasitic diseases have now been identified that can be transmitted by sexual 
route; however, only a minority have the sexual route as their dominant route of 
spread. STDs infect the reproductive tract as their primary site, with the 
transmission occurring during sexual intercourse or during pregnancy and 
childbirth. As a result, the greatest risk of infection is found among sexually 
active individuals and in infants born to infected mothers. Multiple infections 
within the same individual are also frequent, as is re-infection if partners have 
not been adequately treated. 
The vast majority of the disease burden from STDs is a result of the 
complications and sequelae that may follow the infection1. For example, pri­
mary infection with gonorrhoea and chlamydia in women are usually asympto­
matic. Untreated infections may migrate upwards from the lower genital tract 
and lead to pelvic inflammatory disease, chronic pelvic pain, ectopic pregnan­
cies, and infertility. Additionally, untreated infections in pregnant women could 
result in fetal loss, stillbirths, low birth weight, or disease in newborn. 
Furthermore, STDs enhance HIV transmission2'3. 
2. Interaction between STDs and HIV infection 
Classic STDs promote HIV transmission via a variety of biological mechanisms 
by increasing either the infectiousness of the index case, the susceptibility of the 
partner, or both3'4. STD pathogens could disrupt mucosal tissues, and/or 
increase the number of cells receptive to HTV, and/or the number of receptors 
expressed per cell. Cohen with co-workers observed an eight-fold increase in 
secretion of HIV-1 RNA in semen of patients with urethritis in comparison to 
the control group without urethritis, with gonorrhea and trichomoniasis having 
the most substantial effect5. Co-infection with HIV prolongs or augments the 
infectiousness of individuals with STDs, and if the same STDs facilitate 
transmission of HIV, these infections may greatly amplify one another ("epide­
miological synergy")6. 
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3. Epidemiology of STDs 
3.1. Sources of information 
The two main sources of information on the prevalence and incidence of STDs 
are surveillance systems (case-notification reports) and epidemiological studies. 
Nevertheless, the exact magnitude of the STDs burden is frequently unknown8. 
The data from the passive STD surveillance systems is not always reliable or 
complete. The quality and completeness of the available data and estimates 
depend on the quality of STD services, the extent to which patients seek health 
care, the intensity of case finding and diagnosis and the quality of reporting. 
The completeness is further affected by the STD's natural history since a large 
number of infections are asymptomatic. Moreover, only part of the symptomatic 
population seeks health care and even a smaller number of cases are reported. 
The social stigma that usually is associated with STDs may result in people 
seeking care from alternative providers or not seeking care at all. As a result, 
report-based STD surveillance systems tend to underestimate substantially the 
total number of new cases8. 
In Estonia, the surveillance of STDs and HIV infection is based on the manda­
tory universal notification of the newly identified cases to the Counties Health 
Protection Bureaus, which in their turn send monthly reports to the Health 
Protection Inspectorate. Syphilis, gonorrhoea, trichomoniasis, chlamydial 
infection, genital herpes and anogenital wart virus infections, as well as HIV 
infection are all notifiable, and all physicians are compelled to report on them. 
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3.2. Global estimates for major STDs 
The incidence and distribution of STDs varies across space and time7. In 1999, 
the WHO generated the global estimates for four major STDs. These estimates 
suggest that there were more than 340 million new cases of curable STDs in 
adults aged 15-49 years in 1999: syphilis (12 million cases), gonorrhoea 
(62 million cases), chlamydia (92 million cases), and trichomoniasis (174 mil­
lion cases)8, with an estimated 22 million STD cases in Eastern Europe and 
Central Asia (syphilis: 100.000 cases; gonorrhea 3.5 million cases; chlamydia 
6 million cases; trichomoniasis 12.4 million cases)1'8. Geographically, the vast 
majority of these new cases occurred in the developing world (the Third World 
countries) (South and Southeast Asia, Sub-Saharan Africa, Latin America and 
the Caribbean), which reflects the global distribution of population. 
Based on global serological evidence, even more incurable viral infections 
are transmitted each year via the sexual route9. 
3.3 Specific STDs 
3.3.1. Syphilis 
In Western Europe, syphilis prevalence has declined substantially since the peak 
after the World War Et, with incidence rates below 5/100 000 in the majority of 
countries10'11,12. In contrast with the decline in rates observed in Western 
Europe, there has been an alarming increase of the rates in the newly indepen­
dent states of the former Soviet Union since 198913'14. In Estonia syphilis inci­
dence has increased from 3.3 / 100 000 observed in 1990 to as high as 75.7 / 
100 000 of population in 199815. 
3.3.2. Gonorrhoea 
In the years 1980-91, Western Europe experienced, a significant decline of 
incidence of gonorrhoea, which reached below 20 / 100 000 of population.10'17. 
However, since mid 1990s, an increase in cases of gonorrhoea has been ob­
served in some countries (England18, Sweden19). An substantial increase in 
gonorrhoea rates has been detected in Eastern Europe, and in the new inde­
pendent states of the former Soviet Union (with the highest rate in Estonia, 
Russia and Belarus)8. 
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3.3.3. Chlamydiosis 
Genital tract infection caused by Chlamydia trachomatis is a common cause of 
pelvic inflammatory disease with subsequent risk for infertility. The higher 
prevalence of chlamydia observed among female adolescents (24.1%-27%)20'21, 
and the association with young age22 highlights the important role that screening 
of sexually active female play in the prevention of infertility. In Europe, pre­
valence of chlamydia infection amongst pregnant women ranges from 2.7% in 
Italy to 8% in Iceland, with low prevalence and incidence rates in the Nordic 
countries, following a wide scale screening programmes in the 1970s23"27. Pre­
valence data regarding the former Soviet Union countries is limited or missing. 
3.3.4. Trichomoniasis 
In spite of the fact that trichomoniasis is the most common of STDs, the data on 
its prevalence and incidence are limited. High rates of Trichomonas vaginalis 
infection have been found in the developing countries28,29 and in the in­
dustrialised countries30,31. Recently published findings suggest that, even in the 
industrialised countries, diagnostic evaluation and empirical treatment of older 
men with non-gonococcai urethritis32, and partner management in both sexes 
should include treatment for Trichomonas vaginalis32'33. 
In Estonia, trichomoniasis is the most prevalent non-viral STD, with high 
incidence over decades15,16. 
Table 1. STD incidences per 100 000 of population in different countries in 1998 
Syphilis Gonorrhoea Chlamydiosis Trichomoniasis 
Estonia16 75.7 137 237 267 
USA102 2.6 133 237 -
Russian Federation103 235 130 114 317 
United Kingdom104 * 0.4 28 96 -
Finland105 3.6 5.2 207 -
Latvia106 106 50 - -
Lithuania106 63 40 - -
* 1999 
3.3.5. Genital herpes 
Genital herpes is one of the most common STDs worldwide and is associated 
with serious morbidity with a chronic course with unpredictable occurrence of 
recurrences34,35. Genital herpes continues to be epidemic throughout the 
world34,35,36,37. The HSV type-specific serological tests have revealed varying 
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patterns of HSV infection around the world, with HSV 2 infections being far 
more common than previously suspected34, and that HSV 2 seroprevalence is 
rising in many developed countries36,38'39. 
Epidemiological studies of HSV-2 infections have been conducted in several 
countries including the United States, the United Kingdom, Germany, France, 
Italy and Scandinavia36'37,40"44. HSV-2 seroprevalence ranges from 10 to more 
than 20% in most of the studies and is higher among the patients in STD clinics. 
The data describing increasing incidence of primary HSV 1 infection, suggest 
that seroprevalence studies based on HSV-2 type-specific assays underestimate 
overall prevalence of genital herpes45. 
3.3.6. HIV infection 
The human immunodeficiency virus (HIV) that causes AIDS has caused a 
global epidemic far more extensive than what was predicted even a decade ago. 
The UNAIDS and the WHO now estimate the number of people living with 
HIV or AIDS stands at 36.1 million at the end of the year 2000. The regions 
most affected by HIV epidemic are Sub Saharan Africa (adult — 15 to 49 years 
of age — prevalence rate 8.8%), Caribbean (adult prevalence rate 2.3%), and 
South and South-East Asia (adult prevalence rate 0.56%)46. 
Taking into account the continuing expansion of the epidemics in Russian 
Federation (more new HIV infections registered than in all previous years) and 
the Ukraine, by the UNAIDS and the WHO estimates, the number of adults and 
children living with HIV or AIDS in Eastern Europe and Central Asia would be 
700 000 by the end of the year 2000 (adult prevalence rate 0.35%), compared 
with 420 000 just a year ago46. Injecting drug use has played a major role in the 
spread of HIV in Europe. Several countries in Western Europe have reported 
declining HIV incidences among the drug users during the last decade47. In 
contrast, the dramatic increase in HIV incidence in the countries in Eastern 
Europe and in the Russian Federation can be attributed primarily to injection 
drug users48,49. Until the end of 1999, Estonia and Turkmenistan were the only 
successors states of the Soviet Union, where almost no HIV infections among 
injecting drug users (IDU) had officially been reported49. In year the 2000 
Estonia dropped out of the "league of successors" with the HIV epidemic 
among IDUs. 
The data from epidemiological surveys show that within countries and between 
countries in the same region, the prevalence and incidence of STDs may vary 
widely between urban and rural population, and even in similar population 
groups8. In general, the prevalence of STDs tends to be higher in urban 
residents, in unmarried individuals, and in young adults. STDs tend to occur at a 
younger age in females than in males, which may be explained by differences in 
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patterns of sexual activity and in the relative rates of transmission from one sex 
to the other8. 
These differences reflect a variety of social, cultural, and economic factors, 
and also differences in the access to the appropriate treatment. 
4. Factors affecting the transmission of STDs 
Determinants of STD incidence have been described at the individual and 
population level analysis. At the individual level in epidemiological studies, 
various socidemographic characteristics and sexual, health and substance abuse 
behaviours emerge as risk factors or risk markers for being infected with STDs. 
At the population or community level various economic, demographic, organi­
zational, and sociocultural characteristics of populations may correlate strongly 
with STD incidence. At the individual and community level, determinants of 
STD risk tend to be strongly associated with one another and reinforcing and 
magnifying mutual effects50'51. 
4.1. Individual level factors: behavior as risk factors for STD 
Individual-level factors affecting health can be categorised as biogenic (e.g. 
immunologic competence), psychological (e.g. self-esteem) and behavioural51. 
4.1.1. Sexual behaviours 
The dimensions of sexual behaviour that increase risk for infection with STD 
include: early age at sexual debut, large numbers of lifetime and current sex 
partners, nondiscriminating sex partner recruitment patterns, high-risk characte­
ristics of sex partners, specific sexual practices, such as anal intercourse and dry 
sex, frequency and timing of the sexual intercourse, sexual abuse during child­
hood50. 
4.1.2. Health behaviours 
Several health behaviours affect a persons risk for STD. Either decreasing risk 
(consistent and proper condom use, male circumcision, timely health care 
seeking, compliance with therapy and behaviour recommendations, including 
abstaining from sexual intercourse while having STD symptoms) or increasing 
it (unprotected sex, vaginal douching)50. 
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4.1.3. Substance abuse 
Drug use in general constitute a risk factor for sexual transmission of STD. 
Drug use is associated with anonymous sex and sex exchange for drug and 
money; it also reduces the likelihood that safe sex will be practiced. Substance 
abuse (including alcohol abuse) increases the risk having STDs independently 
from the effects of age, race, age at sexual debut, and number of partners50'52. 
In general, risk behaviours tend to occur together. 
4.2. Community level factors related to STDs 
Research on the epidemiology of STDs has dealt predominantly with 
individual- level factors. The awareness of the importance of other factors beside 
individual level factors that contribute to the disease rates is growing ("Syphilis 
as a barometer of community health")53'54. 
The environmental factors affecting health are geographic (e.g. rurality), 
structural and technological (e.g. availability of a vaccine or cure), sociocultural 
(e.g. social support)51, as well as economical. Considerable variations in the 
incidence of STDs assert the social pattern of these diseases55-58. 
The factors of the sociophysical environment associated with the STD 
community rates are geographic (urban areas, proximity to major motorways), 
structural and technological (the availability of treatment services and the 
provision of treatment, number of physicians, disease prevention programs, 
STD outreach programs, needle the exchange programs among injecting drug 
users, social marketing and condom distribution, expenditures for education), 
sociocultural (gender subordination, nationality/race relations, rate of violent 
crime, birth rate) and economic (mean income, unemployment rate)55"58. 
The origins of public health and public order overlap to a great extent and 
they are embedded in the security and stability of personal, domestic and com­
munity networks and other institutions. Disruption of such networks will lead to 
increase of violence, sexuality, substance abuse and general criminality80'92. 
Social disintegration has shown to exacerbate epidemics of other infectious 
diseases beside STDs, including tuberculosis59. 
5. The management of STDs 
The effective management of STD is one of the cornerstones of STD control, as 
it prevents the development of complications and sequelae (including infertility, 
fetal wastage, ectopic pregnancy, anogenital cancer, premature death, neonatal 
and infant infections), decreases the spread of these diseases in the community 
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and offers a unique opportunity for targeted education about HIV prevention. 
Appropriate treatment of STD patients at their first encounter with a health care 
provider is, therefore, an important public health measure60-64. The individual 
and national expenditure for STD care can be substantial. 
5.1. STD case management 
STD case management is the care of a person with an STD-related syndrome or 
with a positive test for one or more STD. The components of case management 
include: history taking, examination, correct diagnosis, early and effective treat­
ment, advice on sexual behaviour, promotion and/or provision of condoms, 
partner notification and treatment, case reporting and clinical follow-up as 
appropriate. Thus, effective case management consists not only of antimicrobial 
therapy to obtain cure and reduce infectivity, but also comprehensive care of the 
patient's needs for reproductive health. 
5.2. Standardized protocols for management of STDs 
The use of appropriate standardized protocols is recommended in order to 
ensure adequate treatment at all levels of the health service. Such standardized 
treatment also facilitates the training and supervision of health providers, delays 
the development of antimicrobial resistance in sexually transmitted agents such 
as Neisseria gonorrhoeae and Haemophilus ducreyi, and is an important factor 
in rational drug procurement60-64. 
5.3. STD management approaches: aetiological and syndromic 
Aetiological approach (i.e. identification of microorganisms prior to the treat­
ment), although correct, avoiding over-treatment and unwanted adverse drug 
reactions is expensive in terms of laboratory costs and it may lead to delayed 
diagnosis and treatment, and might carry the risk of stigma if the clinic is 
designated as an STD clinic61'62. 
To overcome the limitations and the expense of aetiological management of 
STDs, the WHO emphasises an integrated primary care approach using syndro­
mic management61'62. Syndromic management is based on the identification of 
consistent groups of symptoms and easily recognized signs (syndromes), and 
the provision of treatment that will deal with the majority or most serious orga­
nisms responsible for producing a syndrome61,62. In order to maximise the value 
of the syndromic approach, the prevalence of the various STDs and their 
susceptibility to antibiotic treatment need to be known61'65. 
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Estonia has traditionally, managed STDs on an aetiological basis 
(laboratory-based system of diagnosis). Economic difficulties, market reforms 
and political restructuring have had a detrimental impact on the healthcare 
system. Medical services have not received sufficient financial support4'5. Li­
mited resources have led to a situation where specialist STD services are of 
limited availability, and external quality control for laboratory services is 
absent. STD management is further complicated by the lack of consensus 
between different specialists (dermatovenerologists, gynecologists, urologist, 
general practitioners) who deal with STD related problems. 
6. Diagnosis of STDs in Estonia 
Syphilis is diagnosed both clinically and in the case of a primary chancre or 
secondary mucosal lesions by dark ground examination of secretions from the 
lesion for identification of Treponema pallidum. All cases, whether associated 
with clinically manifested infection or not, are confirmed using serological 
tests. Blood is screened using either the Rapid Plasma Reagin (RPR) test or the 
Venereal Diseases Reference Laboratory (VDRL) test. Confirmation is with the 
Treponema Pallidum Haemagglutination Assay (TPHA) and/or the Fluorescent 
Treponemal Antibody-Absorbed (FTA-Abs) test or by immuno-blot testing. 
Antigen detection methods (Enzym immuno assay, Immunofluorescence assay) 
for diagnosing of chlamydial infections became available in 1990 and Chla­
mydia trachomatis culture a few years later. Detection of chlamydial infection 
with the help of DNA amplification tests (Polymerase chain reaction — PCR) is 
not widely available. Gonorrhoea is diagnosed on microscopy of a Gram stained 
smear of genital secretion and by culture on a selective medium. Trichomo­
niasis is identified on microscopy of a wet preparation and by a culture that is, 
taken from urethra or vagina. Availability of cultural and DNA-based diagnostic 
methods is limited to the bigger medical institutions with the suitable laboratory 
back up. 
The diagnosis of genital herpes is frequently made clinically by exclusion of 
other reasons for genital ulcers. Antigen detection is restricted, so far, to a few 
centres and identification by culture method is not available in Estonia. 
Detection of HIV antibodies in Estonia is done by a uniform use of internatio­
nally accepted ELISA kits {Abbott, USA; Ortho Clinical Diagnostics, USA; 
BioRad, France) and positive results are verified by immuno-blot method 
{Ortho Clinical Diagnostics, USA; BioRad, France; Innogenetics, Belgium). 
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AIMS OF THE STUDIES 
The general aim of these theses was to elucidate the epidemiology of sexually 
transmitted diseases in Estonia, with the emphasis on the post-communist 
transition period (1990-2000). Specifically, the aims were: 
1. to evaluate the situation with STDs in Estonia: incidence trends, aetiology 
(Papers I, III, IV, VI); including the secondary aim to define whether 
infection with Trichomonas vaginalis is common enough to include its 
management in a syndromic management protocol (Paper ID) 
2. to identify the individual level risk factors and community level factors that 
may account for the increase in the incidence of STDs — for possible 
implication for disease prevention and control (Papers II, IV, V) 
• to delineate factors sexual / health behaviour and substance (alcohol, 
narcotics) abuse contributing to the STD epidemic in Estonia (Papers II, 
IV) 
• to study the community-level associations and incidence rate of syphilis 
in Estonia during the post-communist transition period (Paper V) 
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MATERIAL AND METHODS 
I. Data collection on STDs 
The data on STDs number of cases and incidence were obtained from the 
national STD case surveillance register; HIV, syphilis, gonorrhoea, trichomo­
niasis, chlamydial infection, genital herpes and anogenital wart virus infections 
cases are reported to the Health Protection Inspectorate (reporting in obligatory 
for the physicians according to the decrees nr. 25 from 12.06.97 and nr. 59 from 
07.01.99 of the Ministry of Social Affairs of Estonia). (Papers I, ID, IV, V) 
Until 1998 the data included a patient's personal identification number. We 
used this to find out people with several concomitant infections and/or persons 
with frequently diagnosed STDs. (Paper III) 
The county syphilis rates were calculated with the Statistical Office of 
Estonia population count estimates66 (1991 through 1999) as the population 
denominator. (Paper V) 
2. Settings, subjects and study designs 
Paper II 
Study activities took place at the Tartu University Clinic of Dermatovenerology. 
A case control methodology was used. 
Between 9/1996 and 6/1998, 301 men and women over the age of 18 were 
recruited. 
The cases were composed of all the participants who presented for care to 
the Tartu University clinic of Dermatovenerology with a diagnosis of Chla­
mydia trachomatis, Neisseria gonorrhoeae, or Treponema pallidum infections. 
Of the 229 clinic registrants approached for study participation, 189 enrolled as 
cases. 
The controls were selected at random from the regional population registry. 
The selected participants were sent a letter describing the study and requesting 
them to contact study representatives at Tartu University Clinic of Dermato­
venerology, A total of 1,100 letters were sent from the registry, and 112 persons 
responded and were enrolled as the controls. The controls were further divided 
as a function of their STD status at the time of enrolment. 
The procedures. After providing informed consent for their participation, all the 
patients who engaged in the study were asked: 
(1) to complete a self-administered questionnaire. 
Participants were asked to report on their lifetime history of STD diagnosis 
prior to study entry, drug use, and of paying for sexual activity. The prevalence 
19 
of alcohol-related problems was determined via the four-item CAGE question­
naire67. Respondents also answered to a series of questions on behaviour in the 
last 3 months, including whether they had been sexually active, had had more 
than three sexual partners, had used condoms consistently (always or almost 
always), had engaged in sexual activity while drunk, had offered money to 
someone in exchange for sex, had had a casual sexual partner, had been 
engaged in anal sex, and whether they had used illicit drugs. Additional 
questions focused on whether respondents believed that their current sexual 
partners had had other sexual partners in the last 3 months and whether they had 
travelled outside Estonia in the past year. Finally, ratings were conducted on 
beliefs regarding STD prevention. The perceived efficacy of different activities, 
such as washing the genital area after having sex, urinating after sex, condom 
use, douching after sex, and using birth control pills, in preventing the trans­
mission of STD was assessed on three-point scales (ineffective, effective, don't 
know). 
(2) to participate in an examination in which cervical or urethral cultures 
were obtained for Neisseria gonorrhoeae and Chlamydia trachomatis (Thayer-
Martin medium, Nouva Aptaca SRL, Italy; McCoy cell monolayers, European 
Collection of Cell Cultures, Salisbury, UK), and venous blood was drawn to 
determine syphilis serologic status (Rapid Plasma Reagin test with fluorescent 
treponemal antibody test for confirmation). 
Statistical analysis. Demographic and behavioural variables were compared 
across groups (i.e., cases, controls with STD, controls without STD) using the 
Fisher exact test for dichotomous variables and t-tests for continuous variables. 
Beliefs about STD transmission were compared across groups using likelihood 
ratio chi-square tests. Odds of having an STD associated with engaging in a 
series of sexual risk behaviours were estimated among those who reported 
sexual activity in the last 3 months via logistic regression models, with group 
and sex included as main effects and a product term included to assess mode­
rator effects. Demographic and behavioural factors that differentiated group 
memberships based on these analyses were selected for inclusion in a multi­
nomial logistic regression model. 
Ethics. All study procedures were approved by the Ethics Board at Tartu 
University and by Institutional Review Board at State University of New York 
Downstate Medical Center. 
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Paper V 
An ecological study methodology was used. 
Periods of post-Communist transition 
Lauristin et al. have divided the post-communist transition in Estonia into the 
three periods68. 
I 1987-1991 — The liberation movements and political breakthrough. 
II 1991-1994 — The restoration of the independent statehood involving radical 
political reforms. 
III 1995-present day — The emergence of a stable democratic system, econo­
mic and cultural stabilization. 
We chose the data of the last years of the first two periods (1991, 1994) and 
1999 as the last year of the third period as for the samples in our statistical 
analysis. 
Sociodemography of counties. The data used in the analysis were provided by 
the Statistical Office of Estonia66'69. Administratively, Estonia is divided into 
15 counties, the smallest with the population of approximately 12,000 and the 
largest of 535.000. The available sociodemographic characteristics of the 
counties were reviewed, and possible markers of socially disruptive situation; 
unemployment as a new phenomenon in post-communist countries; two basic 
demographic variabes, and the tuberculosis incidence rate per 100,000'516 were 
selected for more detailed analysis. These characteristics were: 
(1) the percentage of the non-ethnic Estonians in the population 
(2) the percentage of urban population 
(3) the rate of homicides per 100,000 
(4) the unemployment rate per 100 
(5) the number of live births per 1000 females at age 15-49 
Statistical methods. 
The regression coefficients and the explained variance values were estimated by 
the ordinary least square regression. A five per cent significance level was 
chosen for the p-value of the regression coefficient. Pearson correlation coef­
ficients were calculated. 
Paper VI 
Study activities took place at the Tartu University Clinic of Dermatovenerology, 
Children Hospital, and Hospital of Obstetrics and Gynaecology, South Estonian 
Blood Centre and United Laboratories Tartu University Clinics. 
A cross sectional methodology was used. 
Procedures. A consecutive series of altogether 2845 sera from 1,016 children 
(aged 1-12), 794 1st trimester antenatal women (aged 15-44) and 1,036 blood 
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donors (aged 18-66) whose serum samples had been submitted for serological 
analyses of non-HSV-related diseases were obtained during the first 5 months 
of year 2000. 
Blood donation is voluntary and non-paid in Estonia; screening for blood-
borne infections is mandatory. Blood samples from pregnant women are always 
drawn for screening of congenital infections before week 12 of gestation. 
Children sera were submitted from in- and out patient clinics for biochemistry 
testing. 
Laboratory methods. Baculovirus expressed glycoprotein gGl and gG2 were 
used as antigen in ELISA for detection of HSV-1 and HSV-2 IgG antibodies by 
using commercially available laboratory tests (MRL Diagnostics, Cypress, 
USA). 
Ethics. The Ethics Board of Tartu University approved all study procedures. 
This study was supported by GlaxoWellcome R&D. 
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RESULTS 
1. The post-communist transition period in Estonia 
During the first ten years of independence, a decrease in agricultural and 
industrial production occurred, and the economy became more oriented towards 
provision of services. The role of industrial production declined from 39% to 
31% in 1991-1995, and then it became stabilized. Approximately 6% of Gross 
Domestic Product (GDP) is spent on health care. The two main sources of 
revenue for health care provision in Estonia are the health insurance system and 
the state budget. The public health insurance embraces about 90% of the 
Estonian population; it is based on residency, not citizenship. 
Basic general statistical data show that the health of Estonians has been 
deteriorating since 1990. The death rates due to cardiovascular diseases, 
accidents and poisonings have all risen. In 1994 life expectancy was lowest, 
being for men 61.1 years and for women 73.1, the former having declined from 
66.5 and the latter from 74.9 in 198866, however some signs of improvement 
have been noted in recent years. 
The ethnic composition of the Estonian population has been stable in the 
past decade. Ethnic Estonians comprise about two thirds of the total population. 
There are two regions where the proportion of the non-ethnic Estonians in the 
population is considerably higher than in other places in Estonia: in Tallinn, the 
capital of the Republic of Estonia, non-ethnic Estonians make up nearly 50% 
and in the Ida-Virumaa County (in the North East of Estonia) 72% of the 
population. During the 1990s, the proportions of urban (-70%) and rural 
(-30%) population in Estonia were stable (Figure lc). 
The number of live births has continuously decreased in Estonia during this 
period. The decrease was more rapid in the first half of the 1990s. The decline 
in fertility slowed down in 1993, and a signs of rise in the birth rate began in 
1999 (Figure lb). 
A clear trend can be seen while studying the data on homicides in Estonia 
over the 1990s. The number of homicides began to increase at the beginning of 
the decade. In first period, the homicide rate was more than 8.7 / 100 000. The 
worst year was 1994, with 365 homicides, a rate of 24.4. In the third period, the 
rate of homicide was less than 14 / 100 000. The places of the highest crime 
levels were Tallinn, Narva and Ida-Virumaa County. 
Unemployment was virtually non-existent during the years of socialism. 
After the collapse of the Soviet Union, unemployment maintained a steep and 
steady growth tendency. In 1996, the unemployment rate stabilized at about 8%, 
to start a new rise and reached 12.8% in 1999-2000 under the impact of the 
Russian economic crisis (Figure lb). 
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Figure la. Incidence of syphilis and tuberculosis in Estonia. 
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Figure lb. Homicide, unemployment and birth rate in Estonia. 
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Figure lc. Percentage of non-ethnic Estonian and urban population in Estonia. 
Figure 1. Selected sociodemographic factors, 1991-2000. 
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The incidence of tuberculosis rose from 21.5 per 100 000 in 1991 to 42.3 per 
100,000 in 1999. The majority of the infected were men (approximately 70%), 
and the most affected age group was those between 35-55 (Figure la). 
2. STDs in Estonia in 1990-2000: 
incidence trends, aetiology (Figure 2) 
The syphilis incidence increased from 3.3 per 100 000 in 1990 to 75.7 in per 
100 000 in 1998, a decline in incidence is observed thereafter (also Figure la). 
The available data reporting the ratio of male to female new cases of syphilis 
during the period is quite constant, not exceeding 2:1. Syphilis is most prevalent 
in young adults: in 1992 35% of the infected women were younger than 20 and 
67% of women and 52% of men were younger than 25 years of age. After many 
decades, congenital syphilis was again diagnosed in 1993. Syphilis is focally 
distributed in Estonia; with the striking local differences in the incidence rates. 
There are two counties of the highest syphilis (STD) rates: Tallinn, the capital 
of the Republic of Estonia and Narva, the 3rd largest city situated in the North -
East of Estonia, near the Estonia's border with the Russian Federation 
Years 
Clamydiosis —m—Syphilis Trichomoniasis Gonorrhoea 
Figure 2. Incidence of reported STDs and absolute numbers of HIV positive cases in 
Estonia, 1988-2000. 
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In Estonia the incidence of gonorrhoea is high and almost doubled from 128 / 
100 000 in 1990 to 233 I 100 000 in 1993, but a decreasing thereafter (60 / 
100.000 in 2000). The male to female ratio has remained stable, and as for 
syphilis not exceeding 2:1. The majority of affected individuals of both sexes 
were younger those than 30 years of age. The difference between the two sexes 
could only be observed in the age group under 20, in which approximately 40 % 
more females than males were reported e.g. in 1991 and 1992. 
Chlamydia trachomatis. Almost two thirds of the reported cases were males 
in 1991 and 1992 (the testing was primarily done by dermatovenerologists in 
symptomatic cases). With increased screening of contacts and asymptomatic 
individuals the pattern has completely changed. In 1993 and 1994 over 80 % of 
reported new cases were females. Beginning from 1994 chlamydial genital 
infections outnumbered the reported new cases of gonorrhoea. 
According to reported data Trichomonas vaginalis infections are the most 
prevalent STD in Estonia. The increase in incidence started in early 1990s 
(303.8 / 100 000 in 1990), and is followed by decrease since 1996 to 217 / 
100 000 in 2000. In 1996, the reported incidence was 399.5 / 100 000, being the 
leading STD for men, and frequent cause of male urethritis (Figure 4). 
Nevertheless, approximately 75 % of the reported patients were females and the 
most affected age group is that of individuals between 20-24 years. 
Genital herpes has been a reportable disease since 1991, with an increasing 
incidence over the last 10 years (0.9 / 100 000 population in 1991, 23.9 / 
100 000 in 2000). The magnitude of genital herpes problem is unknown, and the 
increasing trend in current context is most likely indicative of wider recognition 
of the disease by doctors and patients, availability of diagnostic possibilities, 
and less reliable in describing actual epidemiological situation. 
According to the study results, seroprevalences for HSV-2 among children, 
pregnant women and blood donors were 0.5%, 23% and 16%, respectively. A 
sharp increase in HSV-2 seroprevalence was detected among subjects of 15-
40 years of age; but at higher magnitude for women (Figure 3). We found a 
statistically significant difference (p<0.0002) in HSV-2 seroprevalence among 
male blood donors (11%) and female blood donors (21%). A similar increase in 
HSV-2 seroprevalence by age was found among blood donors and pregnant 
women. 
Starting with 1987, the total number of reported HIV seropositive cases has 
been 1169 with the male/female ratio of 914 /255. The numbers of HIV in­
fections have remained very low until recently, even when a considerable rise in 
the incidence of sexually transmitted diseases, especially syphilis, was recorded 
over those years. After the first HIV positive case was recorded in 1988, there 
were 96 cases by 1999. In 2000, a dramatic increase in HIV cases occurred: 
357 new HIV positive cases were reported during the last 4 months of the year 
2000, and additional 683 cases during the first 5 months of the year 2001. The 
available data on the transmission categories of HIV testing single out groups in 
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age-group 
Figure 3. Proportions of seropositives to HSV-2 antibodies by age and gender. 
Estonia with a high HIV incidence — STD patients, sailors, and the sexual 
contacts of HIV-positive persons. According to the data of 2000, we have to add 
a new main transmission category group at risk to those mentioned above — the 
injecting drug users (IDU). Before 1999, only one out of 96 HIV+ cases was 
categorized as an illegal drug user. The cumulative data, including the infor­
mation recorded on HIV testing forms and clinical records testify to the fact that 
IDU was a factor in nearly 90% of the new HIV cases reported in the year 2000. 
The majority of new HIV+ cases (797 (74%)/1037) in 2000 and 2001 are 
reported to be the residents ofn the North-East of Estonia, and this epidemic is 
clearly driven by injection drug use. 
1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 
H Trichomoniasis • Gonorrhea BChlamydiosis 
Figure 4. Proportions of reported cases of STDs causing urethritis in men in Estonia 
1988-1997. 
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3. Analysis of STD data reported to the Health Protection Service 
in Tartu district 
In 1998, in Tartu city and its district, 1558 cases of STDs were reported from 
19 different medical facilities. The male to female ratio was 41:59. There were 
61 cases of syphilis, 92 cases of gonorrhoea, 386 cases of trichomoniasis, 
673 cases of chlamydial infection, 90 cases of genital herpes and 256 cases of 
anogenital wart infection. Of those 1558, 1387 cases (1219 individuals) were 
eligible for further analysis of concomitant infections. In 1998, 46 females 
(5.8%) and 74 males (17.6%) were reported to have co-infection with at least 
two different STDs during the same clinical episode. The most frequent combi­
nation in women was, co-infection with Chlamydia trachomatis and Tricho­
monas vaginalis (36%). In women with more than one infection, Trichomonas 
vaginalis was found in 56% of the cases (Figure 5). In men, Trichomonas 
vaginalis infection was accompanied by chlamydial infection in 28% of the 
cases and by genital wart virus infection in 16% of the cases. In men with more 
than one infection, Trichomonas vaginalis was found in 59% of the cases 
(Figure 5). 
Co-infection with Chlamydia trachomatis and Neisseria gonorrhoeae was 
found in only 9 patients (0.7% of all patients) and the detection of more than 
two STDs, simultaneously, was very rare (13 patients, 1.1% of all persons with 
STDs). Of those with more than two infections 85% were men. 2.9% of the 
patients with proven STDs had repeated episodes within the same year. 
Finally, underreporting of STD cases is obvious. All medical facilities are 
supposed to report their data to the Health Protection Service. In spite of that, in 
Tartu city and its district, 98% of the cases of syphilis, 90% of the gonorrhoea 
cases and 97% of those notified with genital wart virus infection were reported 
from the University Clinic of Dermatovenerology (STD Clinic). Furthermore, 
96% of the cases of trichomoniasis in men and 97% of the cases of 
chlamydiosis in men were reported from the University STD Clinic. 
4. Factors sexual / health behaviour and substance (alcohol, 
narcotics) abuse contributing to the STD epidemic in Estonia 
Participant characteristics. Of the total study participants, 225 (74.7%) tested 
positive for Chlamydia trachomatis, Neisseria gonorrhoeae, or Treponema 
pallidum. Of the 189 cases, 71% were positive for chlamydia, 24.1% for gonor­
rhoea, and 25% for syphilis, 15 were positive for gonorrhoea and chlamydia, 
11 for syphilis and chlamydia, 1 for syphilis and gonorrhoea, and 1 for all 
STDs. Of the 112 controls, 36 (32.1%) were positive for at least 1 STD; 33 for 
chlamydia, 2 for gonorrhoea, and 1 for gonorrhea and chlamydia. No 
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(abbreviations: CT — chlamydiosis, TV — trichomoniasis, HPV — anogenital HPV 
infection, GC — gonorrhea, GH — genital herpes, SY — syphilis). 
Figure 5. Combination of STDs. 
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controls were positive for syphilis. The controls with STD were more likely to 
test positive for chlamydia than the cases (94.4% versus 71.0%, g < .05), and 
less likely to test positive for gonorrhoea (8.6% versus 24.1%, g < .05). 
Respondents' age ranged from 18 to 57 (Mean = 26.5, SD = 6.4). A small 
majority of respondents were female (56.7% versus 43.3% male). The cases 
tended to be younger than the controls; 67.5% of those fell below the median 
age of 25, as opposed to 50.0% of the controls who presented with an STD, and 
36.6% of controls who were not positive for any STD (g < .05). Approximately 
half (54.0%) of the participants included in the study were either married or 
living with a sexual partner. The majority(80.7%) reported that they were 
Estonian, and 15.9% reported a Russian background. A history of drug use was 
reported by 15.1% of the entire sample, with 6.6% reporting a drug use in the 
past 3 months. The drugs reported by those who had used in the past 3 months 
included marijuana (n = 6), cocaine (n = 4), and amphetamines (n = 6). Injection 
heroin use was reported by 1 respondent, who also declared using ketamine. 
The prevalence of a clinically significant CAGE score was 35.2% across the 
entire sample. 
There were no statistically significant differences between the cases, the 
controls with STDs, or the controls without STDs in terms of sex, marital status, 
employment rates, drug use history, or CAGE scores. 
Beliefs about STD prevention. Both the cases and the controls held 
misperceptions about methods for preventing the transmission of STDs, 
although there were no statistically significant group differences in terms of 
level of knowledge. Across the entire sample, 65.2% believed that washing the 
genital area after sex is an effective means for preventing STDs (6.3% reported 
that they did not know), 25.7% believed that urinating afterwards is effective 
(35.8% did not know), 35.5% believed that douching is effective (43.8% did not 
know), and 19.5% believed that using birth control pills is effective (22.2% did 
not know). Most of the participants believed that condoms are effective for 
STD prevention (94.5%); 3.1% claimed that they were unsure about their 
efficacy. 
Univariate behavioural associations with group membership (Table 2). 
Across all groups, the respondents reported that they had recently engaged in a 
series of sexual behaviours (Table 1). In logistic regression models, there was a 
main effect of group membership after controlling for sex across several 
behaviours, including the proportion who reported (1) having a previous STD 
diagnosis (58.1% cases; 26.5% controls with STDs; 40% controls w/o an STD), 
(2) having three or more sexual partners in the last 3 months (21.0% cases; 
5.7% controls with an STD; 8.5% controls without an STD, p < .05), (3) having 
a casual sexual partner in the last 3 months (43.0% cases; 20.6% controls with 
an STD; 20.3% controls without an STD, g < .05), and (4) engaging in sexual 
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Table 2. Univariate logistic regressions predicting behavior as a function of group and 
sex 
Cases (%) 
(N= 189) 
Controls w/o 
STD (%) 
(N = 76) 
Controls w/ 
STD (%) 
(N = 36) 
M F Total M F Total M F Total 
Lifetime history of STD* 55.2 60.6 58.1 29.0 47.7 40.0 27.3 26.1 26.5 
Lifetime history of drug 
use t 24.4 12.0 17.7 19.4 6.8 12.0 18.2 4.0 8.3 
CAGE score indicative of 
alcohol problems f 56.8 19.8 37.0 64.5 18.2 37.3 36.4 16.0 22.2 
Travel outside Estonia in 
the last year t 46.0 32.0 38.5 16.1 31.8 25.3 45.5 36.0 38.9 
Abstinent last 3 months 9.3 9.0 9.1 20.7 16.7 18.3 27.3 12.5 17.1 
Three or more sexual 
partners last 3 months*f 
34.9 9.0 21.0 20.7 0.0 8.5 18.2 0.0 5.7 
Sexual relationship with a 
casual partner last 3 
months*! 56.3 31.3 43.0 40.0 6.8 20.3 36.4 13.0 20.6 
Sexual activity while 
intoxicated on alcohol last 
3 months *t 77.4 58.5 67.4 50.0 38.5 43.1 54.5 45.5 48.5 
Believes partner(s) had 
other sexual relationships 
last 3 months 17.7 20.2 19.2 9.5 15.8 13.6 0.0 21.1 15.4 
Paid for sexual intercourse 
last 3 months f 13.1 0.0 6.0 3.4 0.0 1.4 9.1 0.0 3.0 
Always used condoms last 
3 months 18.8 21.3 20.1 .2 18.4 12.9 0.0 15.0 10.7 
* p < .05 main effect of group membership 
t g < .05 main effect of sex 
t g = .07 interaction of sex * group 
activity while intoxicated from alcohol (67.4% cases; 48.5% controls with an 
STD; 43.1% controls without an STD, g < .05). In turn, the respondents who 
reported engaging in sexual activities while intoxicated were more likely to 
report that in the last 3 months they had been inconsistent condom users (86.3% 
versus 76.4%, g = .055), to have had three or more sexual partners (25.9% 
versus 6.4%,, g < .05), to report a casual sexual relationship (52.6% versus 
19.6%, g< .05), and to have solicited sexual activity (7.8% versus 1.1%, g < 
.05). There were no group differences detected in the proportion reporting 
lifetime drug use, a high CAGE score, travel outside the country in the last year, 
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abstinence in the last 3 months, a belief that the respondent's sexual partners 
had concurrent sexual relationships in the last 3 months, paying for sexual 
activity in the last 3 months, and always or almost always using condoms in the 
last 3 months. 
There were main effects of sex after adjusting for group membership for 
(a) lifetime drug use (22.7% males; 9.5% females, p < .05), (b) CAGE scores 
denoting alcohol problems (56.9% males; 18.8% females, g < .05), (c) three or 
more sex partners in the last 3 months (30.2% males; 5.4% females, g < .05), 
(d) the prevalence of a casual sex partners in the last 3 months (50.8% males; 
22.3% females, g < .05), (e) being intoxicated during sexual activity (69.4% 
males; 51.6% females, g < .05), and (1) paying for sex in the last 3 months 
(10.5% males, 0% females, g < .05). 
Product terms were computed between sex and group membership for each 
behaviour. The interaction predicting travel outside of Estonia in the last year 
approached statistical significance (g = .07), males with STDs were more likely 
to report travel in the past year (46% cases, 45.5% controls with STD) than 
were those without STD (16.1% travel for controls without STD). These 
differences were not seen among women (32% cases, 36% controls with STD, 
31.8% controls without STD). Sexual relationships with new partners while 
travelling in the last year were reported by 16.1% of the male cases, while none 
of the controls reported this behaviour. 
Multivariate behavioural associations with group membership (Table 3). A 
multinomial logit model was conducted to assess for group differences as a 
function of age, STD history, travel, casual sexual partners, having three or 
more sexual partners, sexual activity while intoxicated, and sex (Table 2). A 
product term representing the interaction of sex and travel significantly 
increased the fit of the model, and was also included (x2 difference = 6.9, df = 2, 
g< .05). The resulting equation was statistically significant (x2 = 53.1 (16), 
g < .05), with age, lifetime history of an STD, sexual intercourse while 
intoxicated, and the product term of sex and travel differentiating the groups. In 
terms of age, those less than the median age of 25 were significantly more likely 
to have an STD than were the controls without an STD (OR = 3.3, 95% 
CI = 1.7 - 10.0), and the controls with an STD (OR = 3.3, 95% CI = 1.5 - 10.0). 
The individuals who reported an STD diagnosis prior to the study entry were 
over four times more likely to be the cases then to be the controls with an STD 
(OR = 4.2, 95% CI = 1.6 - 11.2). The only sexual behaviour that differentiated 
group membership after controlling for other factors in the model was whether 
the respondent had been engaged in a sexual intercourse while intoxicated. 
Those engaging in this behaviour were three and a half times more likely to be 
the cases than to be the controls without an STD (OR - 3.5, 95% CI = 1.6 -
7.6). Finally, after controlling for all other variables in the multivariate model, 
there was a statistically significant interaction detected between having travelled 
outside Estonia concerning the sex of the respondent for the comparison of the 
cases versus the controls without STD (OR = 0.1, 95% CI = 0.0 - 0.7), and a 
32 
trend toward statistical significance for the comparison of controls with STD 
versus controls without STD (OR = 0.1, 95% CI = 0.0 - 1.0). These 
interactions reflect the greater odds of STDs among the males who travelled 
(OR = 4.4, 95% CI = 1.5 - 16.0). 
Table 3. Multinomial logit model regressing group membership onto sexual risk 
behaviors. 
Cases vs 
Controls w/o 
STD 
Cases vs 
Controls w/ 
STD 
Controls w/ 
STD vs 
controls w/o 
STD 
Chi-square 
( a l l  d f = 2 )  
OR 95% CI OR 95% CI OR 95% CI 
Male 0.3 1.2 0.6-2.6 1.2 0.5-3.2 1.0 0.3-2.7 
Age greater than 25 15.5* 0.3 0.1-0.6 0.3 0.1-0.7 1.0 0.4-2.6 
Travel outside Estonia in 
last year 
1.4 1.5 0.7-3.2 0.8 0.3-2.0 1.8 0.6-5.1 
Three or more sexual 
partners; 3 months 
0.7 0.6 0.1-2.5 1.4 0.2-9.0 0.4 0.0-3.9 
Sexual activity while 
intoxicated; 3 months 
10.1 * 3.5 1.6-7.6 1.5 0.6-3.8 2.3 0.8-6.5 
Sexual relationship with 
casual partner; 3 months 
3.0 2.1 0.7-6.4 2.1 0.6-7.2 1.0 0.2-4.4 
Ever been diagnosed 
with an STD 
9.8 * 1.6 0.7-3.3 4.2 1.6-11.2 
1-H 1 T
—
«* Ö Ö 
Travel * Male sex 6.9 * 0.1 0.0-0.7 1.1 0.2-6.8 0.1 0.0-1.0 
* p < .05 for the overall parameter estimate. 
5. The community-level determinants and incidence rate of syphilis 
in Estonia during the post-communist transition period 
Statistically significant positive correlation was found between syphilis 
incidence rate and percentage of non-Estonian population (Pearson's r= 0.509), 
urban population (Pearsons r= 0.524), and tuberculosis incidence (Pearson's 
r= 0.444), which explains 25.9 %, 27.5 %, and 19.7 % of the variation in 
syphilis incidence rates across the counties and the three time periods, 
respectively (Table 4). 
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Table 4. Explaned variance, correlation and regression coefficient for the association 
between syphilis rate and six sociodemographic characteristics 
Explained Regression p-value of Correlation 
variance coefficient regression 
coefficient 
coefficient 
Non-Estonian 0.2587 0.738 0.000 0.509 
population(percentage) 
Urban population (percentage) 0.2745 0.841 0.000 0.524 
Homicides Rate (per 100,000) 0.0948 -0.632 0.118 -0.308 
Unemployment rate (percentage) 0.0005 -0.002 0.909 -0.022 
Live births (per 1000 females at 0.2513 
-0.012 0.000 -0.501 
age 15-49) 
Tuberculosis incidence rate (per 0.1974 0.009 0.002 0.444 
100,000) 
A statistically significant negative correlation was also found for syphilis 
incidence rate the birth rate (Pearson's r= -0.501), which explains 25 % of the 
variance. 
No associations between the syphilis incidence rate and the homicides rate 
and the unemployment rate were found (Figure 6, a-f). 
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(abbreviations: SYF RATE — syphilis incidence rate, NONEST_R — proportion of 
non-Estonian, URB_PROP — urban proportion, HOMICIDE_ — homicides rate, 
UNEMPLY — unemployment rate, LIVBIRT — live birth rate, TBCJR — incidence 
of tuberculosis) 
Figure 6. Association of syphilis incidence rate with a) proportion of non-Estonian b) 
urban proportion c) homicides rate d) unemployment rate e) live birth rate f) incidence 
of tuberculosis. 
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DISCUSSION 
A marked increased in incidence of STDs in early 1990s, being most dramatic 
in new cases of syphilis, was observed in Estonia during the time period of the 
great changes in society — a shift from being a Soviet socialist republic to an 
independent country with a new developing market economy. While, the 
incidence of other reported bacterial STD (gonorrhoea, chlamydiosis) started to 
decline in 1994-1995, the trend toward stabilization and decline in incidence of 
syphilis is apparent from 1999 1516 (syphilis is considered as the most reliably 
reported STD in former Soviet Union countries, including Estonia79'81). 
This decline in the STD incidence has been observed not only in Estonia but 
also in the neighboring countries64, and has been attributed to a number of dif­
ferent factors. It has been interpreted as reflecting the peak values having been 
achieved among those socially disadvantaged and at risk, or related to changes 
in care seeking patterns, to implementation of symptomatic treatment without 
the verification of the causative agent, and incomplete case reporting69'74. 
Passive report-based STD surveillance system underestimates the prevalent 
caseload since not all infections are reportable and many patients with STDs are 
asymptomatic and, therefore, do not seek care. Because of the continuing public 
perception of social stigma associated with the acquisition and treatment of an 
STD, many patients do not seek care at all. However, even if they do, as 
elsewhere in the world, misdiagnosis and underreporting obligation may occur. 
For example in 1998 in Tartu city and its district, 98% of cases of syphilis, 90% 
of gonorrhoea cases and 97% of those notified with genital wart virus infection 
were reported from the University Clinic of Dermatovenerology. Bearing in 
mind that many infections are asymptomatic, the diagnosis of STD may be 
completely overlooked (lack of expertise) or STD cases not reported to county's 
Health Protection Bureaus by other doctors (family doctors, gynaecologists and 
urologists) than dermatovenerologists. 
In Estonia, trichomoniasis and chlamydial infections are the most prevalent 
non-viral STDs. In men, trichomoniasis has been associated with prostatitis, 
epididymitis and infertility with the strongest association being with non­
gonococcal urethritis. Balanitis and posthitis have been described with tricho­
moniasis and, in severe cases, penile ulceration too70. In women, vaginitis and 
vulvitis are the main clinical conditions71. Recent studies have shown an 
association between trichomoniasis and low birth rate of babies (independent of 
HIV infection and other risk factors associated with low birth rate)72,73 and pre­
term labour73. As a classic STD, trichomoniasis may facilitate HIV transmission 
in both ways — increasing the infectiousness of and susceptibility to HIV 
infection74. Degradation of secretory leucocyte protease inhibitors (SLPI) is 
associated with trichomonal infection. SLPI is believed to limit the transmission 
of HIV infection by inhibiting virus entry into monocytes (in vitro)15. The data 
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from Laga and her colleagues show an association between trichomoniasis and 
acquisition of HIV infection in women, with estimated relative risks ranging 
from 1.8 to 3.078. Urethral infection with gonorrhoea and trichomoniasis has 
been found to have a significant effect on HIV-1 RNA excretion76,77. Algo­
rithms for the management of urethral discharge in men have been evaluated 
and proven to be valid and sensitive 61 but, with a caveat: that the chosen 
antimicrobial regimens should cover the major pathogens responsible for the 
syndromes in a specific region1. By ignoring trichomoniasis as a cause of 
urethritis in men in a setting where trichomoniasis prevalence is high, basic 
syndromic management targets might be missed: firstly, effective treatment of 
the genital tract at the first visit and patient satisfaction61,65. The first visit may 
be the only opportunity to treat and counsel as follow-up rates in men can be 
low65. In Estonia, trichomoniasis accounts for 35% of cases of male 
urethritis15,16 and is found in 59% of men with mixed STDs (in a situation where 
major target of urethritis treatment in context of syndromic management — co-
infection with Chlamydia trachomatis and Neisseria gonorrhoeae is rare). Thus, 
it might be reasonable to include metronidazole among the first line treatments 
for the urethral discharge syndrome in men. In Estonia, the management of 
STDs and control efforts are limited and a specialist service using full labora­
tory facilities is expensive and is in fact only accessible to urban residents near 
centres with laboratory support. In Soviet times, the healthcare system was 
centralised with STD care being mostly provided through dermatovenereology 
clinics which used a laboratory-based system of diagnosis. After independence 
in Estonia, while the centralisation of services is less, it may be appropriate, 
outside the main centres, to provide care for STDs within the primary healthcare 
system 79. In the primary care setting, there would be considerable advantage to 
the use of syndromic STD management protocols, and in Estonia the inclusion 
of metronidazole amongst the medications used for the urethral discharge 
syndrome would be appropriate. 
Increased rates of STD in Estonia are associated with patterns of sexual risk 
behaviours. Factors contributing to increased rates of STD among men and 
women include risk factors typically associated with STD epidemics; these 
include the prevalence of multiple sexual partners, engaging in sexual relation­
ships with casual partners, engaging in a sexual activity with new partners while 
travelling outside of the country, and engaging in sexual activity while intoxi­
cated. In addition, an inaccurate understanding of STD transmission dynamics 
may further contribute to the STD occurrence. 
The cases and the controls, in our study exhibited similarly high levels of 
misconceptions regarding methods for preventing disease transmission. Al­
though this population was generally aware of condom use as an effective 
prevention tool, over 65% believed that washing the genital area is effective, 
and 20-33% of the population believed that using birth control pills, douching 
after intercourse, or urinating after intercourse are also effective. Incorrect 
knowledge regarding these issues may place individuals at increased risk for 
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HIV/STD if they rely on these behaviours for disease prevention; education 
regarding the efficacy of different modes of disease transmission and prevention 
is important in this population. 
Those who indicated recent alcohol intoxication during sexual intercourse 
were more likely to be the cases than to be the controls testing negative for 
STD. Individuals reporting this behaviour were also more likely to have 
multiple and casual sexual partners, to have engaged in sex exchange behaviour, 
and were less likely to report using condoms consistently. These findings, when 
coupled with the fact that over a third of the population had a CAGE score that 
indicate alcohol-related problems, suggest that identification and treatment of 
alcohol addiction may be an important component of disease control in this 
population. 
This study on individual factors associated with STD occurrence is limited 
by the low rate of response from the mail recruitment of controls; the 
assumption that this sample is representative of the general population should 
be taken with caution. It is possible that controls who responded to the letter 
may have done so in order to receive the STD examination and treatment that 
was included as part of study participation. For these reasons, some of the 
marked differences may be attributable to the sample selection, such that those 
with suspected conditions were more likely to respond. Provided that there were 
still statistically significant behavioural differences between the cases and 
controls, however, this supports rather than detracts from the contention that 
these two groups are fundamentally different. Furthermore, those individuals 
with STD in the control group were more likely to have chlamydiosis, and less 
likely to have had gonorrhoea or syphilis. Given that symptoms of chlamydiosis 
are often less noticeable than these other diseases, it seems justified to conclude 
likely that those individuals were probably unaware of their disease, rather than 
avoiding treatment for a suspected condition. The findings suggest that this 
population segment may benefit from the efforts aimed at greater outreach and 
screening, coupled with sexual risk reduction counselling. 
Social disintegration has proven to exacerbate epidemics of infectious 
diseases, including AIDS, and tuberculosis, and behavioural pathologies such as 
substance abuse and violence80. The lack of economic equilibrium and insecu­
rity have deepened in the society, and on the other hand, the freedom to make 
own decisions has increased without a simultaneous consciousness of respon­
sibility. Especially in case of STDs, societal factors tend to influence risk 
behaviour and consequently the probability of being infected. First, society 
provides the context in which behaviours are shaped and conducted. Syphilis is 
a classical example of STD. 
In our study on community level associations of syphilis incidence rate, 
constantly higher syphilis incidence rates were identified in Tallinn and Ida-
Virumaa County, the regions with high percentage of non-ethnic Estonian 
population and unemployment rate. Syphilis rate was positively associated with 
the proportion of non-Estonian (Pearsons r=0.509), but we found almost no 
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association with unemployment rate. The ethnic origin is not considered to be a 
biological risk factor for syphilis; ethnicity is probably a marker of interrelation­
ships of ethnicity with other socioeconomic and demographic factors. Socially 
disruptive situation is a critical and unique environmental condition that may 
trigger syphilis epidemic82. Due to the language-based labour division during 
the Soviet period, changes in society had affected Estonians and non-ethnic 
Estonians in different ways. The Russian-speaking population is predominantly 
occupied in those branches of the economy, which have been deteriorating since 
the restoration of Estonia's independence, intensifying the problem with the 
unemployment. 
The unemployment rate in our study did not correlate with the syphilis rate. 
There could be several explanations to this finding. The unemployment is the 
greatest problem in the North-East of Estonia (as there are too many oversized 
enterprises that were subordinated to centralized control from Moscow) and in 
the South of Estonia (mostly dominated by the enterprises of agriculture, 
fishing, forestry)83, yet the syphilis incidence in the two above-mentioned areas 
is different. Another region with a high STD rate is Tallinn with its good job 
opportunities and low unemployment rate. 
The theories on STD transmission have drawn the readers' attention to 
importance of current prevalence of infection in population108, and to social 
networks89'90. The capital city of Ida-Virumaa county, Narva, is located on a 
cross-border motorway between Estonia and the Russian Federation, and con­
necting Tallinn with St Petersburg — an area with extremely high STD rates, 
especially syphilis incidence is also faced with serious STD problems. So in 
1998, the incidence of syphilis in Estonia was 75.7 / 100,000 population, but in 
Narva it was 258.8 / 100,000 population 15 that is comparable to the syphilis 
incidence in the Russian Federation (234 / 100,000 population)91. Major motor­
ways may serve as conduits for illegal drug trafficking. Drugs are known to 
have a potential of altering sexual mixing patterns88. The data assured also by 
our case-control study on sexual beliefs and behaviours determining that sexual 
behaviour on travel might contribute to STD rates. 
Another marker of social integration is the rate of live birth, which in this 
study was inversely associated with county syphilis rate (Pearsons r= -0.501). 
Large population downturn (including decrease in birth rates) during 
transition period radical socioeconomic changes is also characteristic of other 
Eastern European countries84. During the last decade, Estonia lost 8% of its 
population compared to the pre-transition period (1989)66. This phenomenon is 
assumed to be the consequence of the drastic changes in political, economic and 
social conditions83. The rate of legitimate birth is continuously falling, and the 
mean age of women at child birth and the mean age of women at the birth of the 
first child were steadily increasing during the nineties66. 
The high incidence rate of syphilis was observed in Tallinn, the capital of 
Estonia. Urban residence has been proven to be associated with high syphilis 
rates85, although there may also be a surveillance artefact, with better access to 
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medical care in urban areas,86 resulting in higher rates of appropriate diagnosis 
and reporting syphilis cases. In this study, the proportion of urban population in 
the county was strongly associated with the county's syphilis rate (Pearsons 
r=0.524). Age specific migration rates revealed that the growth of internal 
migration had mostly taken place on account of the decrease of non-registered 
changes of the place of residence of 15-34 year old males and 15-29 year-old 
females87 — the age groups most vulnerable to STD related problems. 
The disruption of public health and public order, instability of personal, 
domestic and community networks will lead to the increased levels of violence, 
sexuality, substance abuse and general criminality92. In Estonia a substantial 
increase of IDU began in 1994, and it is still escalating. According to the 
Estonian Health Statistics the number of patients admitted for care for 
psychiatric and behavioural disorders caused by the use of illegal drugs more 
than tripled during the late 1990s (24.5 / 100000 in 1995, 82.2 / 100 000 in 
1998)107. Unfortunately, no verified data on the extent of drug abuse are 
available, but the number of IDUs in Estonia is estimated to be 10.000-12.000; 
the majority is Russian-speaking (90%) males, aged 15-25 (85%) heroin 
addicts93'94'95. The marked increase in HIV incidence in Estonia was preceded 
by an increase in the numbers of the registered cases of hepatitis B and hepatitis 
C 15, which was considered to be associated with the spread of injecting drug 
use in Estonia93,96'97. The increase may also be the result of the change in the 
pattern of drug use93, from smoking drags to injecting drugs. The period of 
1994 to1997, indicated an almost five-fold increase in the absolute numbers of 
the registered new cases of hepatitis B and C in the age group of 15-19 years 
old; 50% of hepatitis B and 52% of hepatitis C cases were diagnosed in this age 
group in the year 199796. One of the interesting observations from the last 
decade of the 20th century Estonia is that the number of HIV infection cases 
remained relatively low, regardless of the rapidly and substantially increasing 
STD rates (syphilis in particular) (Figure 2). HIV epidemic began to develop 
only after it was introduced to the drug injecting community. In Estonia, the 
current data, including the information recorded on HIV testing forms98 and 
clinical records93'99 document the fact that IDU was a factor in nearly 90% of 
the new HIV cases reported in the year 2000. 
The majority of new HIV+ cases (797 (74%)/1037) in the years of 2000 and 
2001 are reported to be residents in the North-East of Estonia, and this epidemic 
is clearly driven by intravenous drag use93'98'99'100. 
In addition to STDs, social disintegration has shown to exacerbate epidemics 
of several other infectious diseases including tuberculosis59. We found that 
syphilis rate was positively associated with the tuberculosis incidence rate, 
which further supports the similar risk factors for these infections, e.g. social 
disintegration. 
Our study on association between community level determinants and syphi­
lis incidence rate is limited in several ways: we used data from passive STDs 
surveillance systems (as explained above), and so we could underestimate the 
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real burden of the disease; we only used the available county-level data. There 
is an absence of reliable national level data on sexual behaviour and alco­
hol/substance abuse. However, this ecological analysis used the unique social 
and political situation with radical changes in community in a very short period, 
and it demonstrated the important associations between community-level 
indicators and the rate of syphilis incidence. The results support the theory of 
syphilis as a social disease, with the considerable variation of the incidence of 
syphilis across space and time, asserting the social pattern of the disease. 
ii 41 
CONCLUSIONS 
The study results demonstrate high rates of sexual risk behaviour and 
inadequate knowledge regarding prevention of disease transmission. 
In a case-control study of beliefs on behaviours associated with STDs, 
across the entire sample, 65.2% believed that washing the genitals after sex 
is an effective mean for preventing STD; despite that almost all respondents 
(94.5%) were aware that condom use protects against STD, less than one-
fifth reported always or almost always using condoms. These factors signify 
that basic health education and promotion efforts implemented across the 
entire population should be public health priorities. 
The 32% STD prevalence rate among those recruited as controls indicates 
that effective STDs identification and treatment is of utmost importance. The 
importance of effective measures in STD control is further emphasised in the 
light of the advent of HIV/AIDS epidemic in Estonia — the high rate of 
STDs (including infectious syphilis), indicate the country being susceptible 
to the possibility of the epidemic spread of HIV infection via heterosexual 
intercourse, into the general population. 
HIV infection appeared much later in Estonia than in many other parts of the 
world. The HIV outbreak was preceded by more than a decade of a "silent 
HIV infection" in our community. Rapidly increasing rates of HIV in 
Estonia require immediate efforts to promote risk reduction including 
behavioral intervention programs targeting ID Us and their sexual/drug using 
partners, syringe needle exchange and distribution programs, substitution 
pharmacotherapy, outreach to IDUs, peer education programs. The expertise 
of the other countries that confronted with the challenges of HIV earlier 
could be of great help and importance for Estonia. 
These results underline the importance of the socioeconomic and demo­
graphic factors, and the complex social dimensions of public health prob­
lems. We found statistically significant relationships between the syphilis 
incidence rate and such community level factors as the percentage of non-
ethnic Estonians in the population (Pearsons r=0.509), the percentage of 
urban population (Pearsons r=0.524), the tuberculosis incidence (Pearsons 
r= 0.444) and the birth rate (Pearsons r=-0.501). Our findings illustrate the 
same origins of the public health and public order, and emphasize the 
importance of establishing close ties between the health care sector and the 
other community resources to prevent sexually transmitted infections. 
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SUMMARY IN ESTONIAN 
Sugulisel teel levivad infektsioonid Eestis aastatel 1990-2000, 
epidemioloogiline uuring 
Sugulisel teel levivad infektsioonid (suguhaigused) on juba aastaid tõsine prob­
leem kogu maailmas. Inimese immuunpuudulikkuse viiruse (HIV) põhjustatud 
ja teistel sugulisel teel levivatel haigustel on olulised sotsiaalsed, demograa­
filised ja majanduslikud tagajäijed. 
Sugulisel teel levib üle 30 nakkushaiguse, kuid üksikute jaoks on see leviku-
viis peamine. Suguhaigustest on kõige enam ohustatud seksuaalselt aktiivsed 
inimesed ja suguhaigusi põdevatelt emadelt sündivad lapsed, sest suguhaigused 
infitseerivad suguteed ja nende ülekanne toimub sugulise vahekorra või sünni­
tuse ajal. Suguhaigused on olulised just eelkõige (1) oma tüsistuste ja kaugtaga-
järgede tõttu. Näiteks on gonorröa või klamüdioosi esmasinfektsioon naistel 
sageli asümptomaatiline, kuid ravimata infektsioonile järgneb põletiku ülenemi­
ne suguteedes, põhjustades väikse vaagna põletikulist haigust, kroonilist valu-
sündroomi, emakavälist rasedust ning viljatust. (2) Ravimata põletikud sugu­
teedes on seotud raseduse katkemise, madala sünnikaalu ning loote ja/või 
vastsündinu haigestumisega. (3) Suguhaigused soodustavad HIV-infektsiooni 
ülekannet, suurendades nii nakkuslikkust kui ka vastuvõtlikkust. Suguteede 
limaskesta põletik suurendab HIV-infektsiooniga nakatumisevõimeliste rakkude 
arvu piirkonnas ning rakkudel ekspresseeritud retseptorite arvu. HIV+uretriiti 
põdevad mehed eritavad oma spermaga oluliselt rohkem HI-viiruseid kui 
HIV+mehed, kel uretriiti ei ole. Olemasolev HIV tüsistab oluliselt teiste sugu­
haiguste kulgu organismis. 
Suguhaigustesse haigestumise jälgimiseks on kaks peamist allikat: haigus-
järelvalve riikliku andmehõive raames (uute haigusjuhtude registreerimine) ja 
epidemioloogilised uuringud. Eestis kuuluvad HIV-infektsioon, süüfilis, gonor­
röa, trihhomonoos, klamüdioos, suguelundite herpes ja kondüloomid kohus­
tuslikus korras registreerimisele maakondade tervisekaitsetalitustes, vastavalt 
sotsiaalministri määrustele nr. 25 (12.06.1997) ja nr. 59 (07.01.1999.). 
Haigusjärelevalvel juhtude kohustusliku registreerimise kaudu saadud infor­
matsioon ei ole alati täielik ja usaldusväärne. See sõltub suguhaiguste ravi­
asutuste olemasolust ja töö kvaliteedist (haiguste korrektne diagnoosimine ja 
haigusjuhtude registreerimine, uute haigusjuhtude — kontaktsete avastamine ja 
ravi), patsientide pöördumisest kontrollile ja ravile. Probleemi muudab keeru­
kaks ka suguhaiguste sage asümptomaatiline kulg, mistõttu patsiendid ei pöör­
dugi arsti poole. Kõige tõenäolisemalt alahindab registreerimisel baseeruv hai­
guste järelevalve süsteem oluliselt tegelikku suguhaigustesse nakatumist. 
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Võrdlevalt on esitatud haigestumus mõnedesse suguhaigustesse 1998. aastal 
Eestis, Vene Föderatsioonis, Inglismaal, Soomes ja Ameerika Ühendriikides 
tabelis 1. 
Haigestumus süüfilisse ja gonorröasse on arenenud Euroopa riikides madal. 
Klamüdioos on neis riikides üks sagedasim suguhaigus. Põhja-Euroopa riikides 
on klamüdioosi haigestumine vähenenud seoses efektiivsete ennetusprogram-
mide rakendamisega. Trihhomonoos on kõige sagedam suguhaigus maailmas, 
sellele vaatamata andmed selle haiguse kohta sageli puuduvad; haigust on 
arenenud Euroopa riikides harva. Genitaalherpes-infektsioon on eluaegne, tema 
kulg krooniline, retsidiveeruv ja ettearvamatu. HSV tüübispetsiifiliste testidega 
tehtud uuringud näitavad, et see infektsioon on sagedasem, kui varem arvati, et 
piirkonniti on infitseeritus erinev ning et HSV-2 seroprevalents paljudes 
arenenud riikides suureneb. 
HlV-infektsiooni epideemia on ulatuslikum, kui oletati veel dekaad tagasi. 
MTO ja UNAIDSi andmeil elas aastal 2000 maailmas 36,1 miljonit HIV-ga 
infitseeritud inimest. Kõige rohkem on nakatunuid Kesk-Aafrikas (haiguse 
levimusmäär täiskasvanute hulgas 8,8%), Kariibi mere saartel (levimusmäär 
2,3%) ning Lõuna- ja Kagu-Aasias (levimusmäär 0,56%). Arvestades jätkuvalt 
kõrget haigestumust Ukrainas ja Vene Föderatsioonis, on MTO andmeil Ida-
Euroopas ja Kesk-Aasias HIV-infektsiooni levimusmäär täiskasvanute seas 
aastal 2000 0,35% ning peamiseks nakkuse leviku viisiks parenteraalne nakkus 
süstivate narkomaanide seas. 
Eestis sagenes haigestumine suguhaigustesse tuntavalt möödunud dekaadil; 
haigestumise tõus oli ilmne, vaatamata muutustele haigusjärelevalves ja puu­
dulikule haiguste registreerimisele. Kuigi traditsioonilistesse suguhaigustesse 
(süüfilis, gonorröa, trihhomonoos, klamüdioos) nakatumine oluliselt sagenes jäi 
haigestumus HIV-nakkusesse Eestis peaaegu kümneks aastaks madalale tase­
mele. HIV-sse haigestumuse märkimisväärne tõus vallandus 2000. aastal seoses 
nakkuse levikuga süstivate narkomaanide seas. 
Suguhaiguste epidemioloogia kirjeldab neisse haigestumist, haiguste levi­
must piirkonniti ja ajaliselt ning selle muutusi. Epidemioloogilised uuringud on 
näidanud, et haigestumus ja levimus on piirkonniti ja ajas erinev, mis peegeldab 
suguhaigustesse haigestumist määravate tegurite varieerumist. Tavaliselt on 
haigestumine kõrgem linnades, noorte ja vallaliste isikute seas. Suguhaigusi 
põevad naised nooremalt kui mehed. 
Suguhaigustesse nakatumist määravaid tegureid saab käsitleda kahel — 
indiviidi (bioloogilised ja psühholoogilis-käitumuslikud tegurid) ja sotsiaalsel 
tasemel (geograafilised, tehnoloogilised, strukturaalsed, kultuurilised, majan­
duslikud faktorid). Indiviidi tasemel on suguhaigustesse nakatumisega seotud 
mitmesugused seksuaal- ja tervisekäitumise vormid ning erinevate ainete 
kuritarvitamine. Kõrgenenud riskiga on seotud varajane seksuaalne debüüt, 
seksuaalpartnerite suur arv kogu elu jooksul ja käesoleval ajal, valimatu 
seksuaalpartnerite valik ja teatud seksuaaltehnikad (anaalne seks, "kuiv" seks), 
seksuaalvahekordade sagedus ja ajastamine (nt haigustunnuste esinemise ajal), 
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seksuaalne kuritarvitatus lapseeas. Erinevad tervisekäitumise mustrid mõjuvad 
kas nakatumisvõimalusi vähendavalt (pidev ja korrektne kondoomi kasutamine, 
ringlõikus meestel, arsti poole pöördumine ja ravi- ning režiiminõuete järgi­
mine) või suurendavalt (kaitsmata seksuaalvahekorrad, tupeloputused). Ainete 
kuritarvitamine (k.a alkohol) on riskifaktoriks nakatumisel suguhaigustesse, 
sõltumata vanusest, vanusest seksuaalse debüüdi ajal ja seksuaalpartnerite 
arvust. Sageli esinevad individuaalsel tasemel mõjuvad riskifaktorid koos. 
Suguhaiguste epidemioloogilised uuringud keskendusid varasematel aastatel 
indiviidi tasemel mõjuvate faktorite uuringuile, praegu kasvab huvi ühiskonna 
tasemel mõjurite vastu. Kirjeldatud on rida sotsiaalfüüsikalisi faktoreid seoses 
suguhaigustesse haigestumisega: geograafilised (linnad, suurte maanteede lähe­
dus), tehnoloogilised (vaktsiini või ravi ja raviasutuste ning arstide, haiguse 
ennetusprogrammide, süstalde vahetamisprogrammide, kondoomide kättesaada­
vus ja turustamine), sotsiaalkultuurilised (sugudevaheline subordinatsioon, 
rahvussuhted, kuritegevus, sündimus, hariduskulutused) ja majanduslikud (töö­
tus, keskmine sissetulek). 
Adekvaatne ja nõuetele vastav suguhaiguste ravi ja käsitlus on äärmiselt 
tähtis. Haigusjuhu käsitlusse kuuluvad anamneesi kogumine, läbivaatus, diag­
noosi püstitamine, ravi ordineerimine, nõustamine, kondoomi kasutamise 
promotsioon, partnerite/kontaktsete selgitamine ja ravi, haigusjuhu registree­
rimine ja vajadusel järelkontroll. Suguhaiguste raviks on väljatöötatud standar­
diseeritud käsitlusprotokollid erinevatele arstiabi osutamise tasemeile. Lisaks 
haiguste efektiivsele ravile on nende protokollide järgimisel eelised: aitavad 
kaasa meditsiinitöötajate väljaõppele ja nende töö hindamisele, lükkavad edasi 
ravimiresistentsuse teket ning on vajalikud efektiivsete ravimitega varustamise 
planeerimiseks. Eestis on suguhaiguste ravis kasutusel etioloogilisel diagnoosil 
põhinev printsiip. Etioloogiline ravi on küll korrektne ja väldib üleravimist, 
kuid kallis (laboratoorsete uuringute, transpordi- jm kulud), mistõttu ravi 
alustamine viibib, lisaks on veel senini säilinud soovimatus, (vale)häbi sugu­
haiguste raviga tegelevasse asutusse pöörduda. 
Arengumaade jaoks on MTO juhtimisel väljatöötatud nn. sündroomse ravi 
protokollid. Sündroomne ravi põhineb koosesinevatel ja kergesti äratuntavatel 
sümptoomidel (=sündroom) ning ravil, mis on efektiivne enamuse või kõigi 
nimetatud tunnuseid põhjustavate mikroorganismide likvideerimiseks (nt uret-
riidi ravimisel tehakse korraga gonorröa ja klamüdioosi ravi). 
Teesides esitatud uuringute eesmärgid 
Analüüsida Eestis sugulisel teel levivatesse infektsioonidesse haigestumist 
aastatel 1990-2000, et selgitada haigestumise kiire tõusu põhjusi. 
1. Selgitada suguhaigustesse haigestumist aastatel 1990-2000: trendid, sugu­
haiguste etioloogia (artiklid I, HI, IV, VI); kaasuvalt selgitada, kas trihhomo-
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noosi nakatumine on nii sage, et oleks põhjendatud metronidasooli lülitamine 
uretriidi sündroomse ravi protokolli (artikkel III). 
2. Selgitada ja analüüsida indiviidi ja ühiskonna tasemel määravaid faktoreid 
suguhaigustesse nakatumisel (artiklid II, IV, V): 
• välja tuua seksuaal- ja tervisekäitumise ning ainete kuritarvitamise iseära­
sused, selgitada seos haigestumisega suguhaigustesse (artiklid II, IV); 
« uurida ja analüüsida ühiskonna tasemel määratavaid faktoreid seoses sugu­
haigustesse haigestumise tõusuga aastatel 1990-2000 Eestis (artikkel V). 
Materjalid ja meetodid 
1. Suguhaigustesse haigestumise andmete kogumine. 
Haigusjuhtude registreerimise andmed maakondade tervisekaitsetalitusest lae­
kuvad tsentraalselt Tervisekaitseinspektsiooni. Kõik arstid peavad kohustuslikus 
korras registreerima HIV-nakkuse, süüfilise, gonorröa, klamüdioosi, trihhomo-
noosi, suguelundite herpese ja kondüloomid. Registreerimiskord ei ole uuringu-
aluse ajajooksul muutunud. 
2. Uuritavad ja uuringu ülesehitus. 
Artikkel II. Juht-kontrolluuringu tegime Tartu Ülikooli naha- ja suguhaiguste 
kliiniku polikliinikus, 09.1996-06.1998. a. Juhud: 189 polikliiniku patsienti 
diagnoositud suguhaigusega (süüfilis, gonorröa, klamüdioos). Kontrollrühm: 
Eesti rahvastikuregistri Tartu linna ja maakonna elanike hulgast juhuvaliku teel 
teostatud valimisse kuulus 1100 isikut, kellele saatsime koju kutse osaleda 
uuringus — osales 112 isikut. 
Uuringu protseduurid: (1) kõik osalejad täitsid küsimustiku, mis käsitles 
seksuaalkäitumist, tervisekäitumist, ainete kuritarvitamist ja teadmisi sugu­
haiguste vältimise võimalustest; (2) kõigil tehti uuringud suguhaiguste diag­
noosimiseks; kõik uuritavad allkiijastasid informeeritud nõusoleku vormi. 
Artikkel V. Ökoloogiline uuring, kus kasutasime postkommunistlike ülemi­
nekuaastate perioodiseerimist vastavalt M. Lauristini (1998) pakutule: 1987— 
1991 vabadusliikumise ja poliitiline läbimurre; 1991-1994 sõltumatu riigi 
taastamine, radikaalsed poliitilised reformid; 1995. aastast alates stabiilse demo­
kraatliku süsteemi kujunemine, majanduslik ja kultuuriline stabiliseerumine. 
Administratiivselt on Eesti Vabariik jagatud 15 maakonnaks. Analüüsiks kasu­
tasime lisaks haigestumusele tuberkuloosi ja süüfilisse järgmisi maakondi 
iseloomustavaid andmeid Eesti Statistikaametilt: mitte-etniliste eestlaste ja 
linnaelanike osa rahvastikus, tapmiste määr 10 000 inimese kohta, töötusemäär, 
elussündide arv fertilises eas naistel. 
Artikkel VI. HSV-infektsiooni seroepidemioloogiline läbilõikeuuring, kasu­
tades kliinilistel eesmärkidel kogutud seerumi ülejääke HSV-serotüübiliste 
testide tegemiseks. Kokku analüüsiti 2845 seerumit: 1016 lastelt, 794 rasedailt 
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ja 1036 doonoreilt. Kasutasime HSV-tüübispetsiifilist testi firmalt MRL 
Diagnostics, Cypress, USA. 
Tulemused ja arutelu 
Süüfilisse haigestumine tõusis 1990.-1998. aastal 23 korda: suurenedes vasta­
valt 3,3 haigusjuhult 75,7 haigusjuhule 1 000 000 kohta (joonised la ja 2). 
Pärast 8-aastast haigestumise tõusu langes 1999. a esmakordselt süüfilisse 
haigestumise tase 24%, moodustades 57,8 /100 000. Aastal 2000 see tendents 
jätkus. Gonorröasse haigestumus, mida Eestis iseloomustavad suured kõikumi­
sed eri aastakümnetel, on meil samas alati suhteliselt kõrge olnud, iseseisvus­
perioodi alguses see kahekordistus. Klamüdioosi haigestumus tõusis perioodi 
alguses oluliselt ning 1994. a oli esimene aasta, kui klamüdioosi haigestumus 
ületas gonorröasse haigestumuse. (Klamüdioosi haigestumise tõus perioodi 
algul kirjeldab eelkõige vastava diagnostika juurutamist Eestis neil aastatel.) 
Trihhomonoos on Eestis kõige sagedamini diagnoositav suguhaigus (joonis 2). 
Tartu Tervisekaitsetalitusse laekunud 1998. a registreeritud haigusjuhtude ana­
lüüsi tulemuste kohaselt oli trihhomonoos diagnoosimise sageduselt klamü­
dioosi järel teisel kohal, olles sagedasimaks uretriidi põhjustajaks meestel ning 
esines sageli kombinatsioonis teiste suguhaigustega (joonised 4 ja 5). Alates 
1994. aastast võib Eestis täheldada mitmetesse suguhaigustesse haigestumise 
vähenemist (gonorröa, trihhomonoos, klamüdioos). Teadusajakirjanduses on 
arutletud suguhaigustesse haigestumise vähenemise põhjuste üle viimastel aas­
tatel nii Eestis kui ka teistes hiljuti iseseisvunud riikides. Võimalike põhjustena 
tuuakse ära suguhaiguste puudulikku registreerimist arstide poolt, ühiskonna 
stabiliseerumist, aga ka asjakohaste ja efektiivsete raviskeemide rakendamist. 
Seksuaal- ja tervisekäitumist ning ainete kuritarvitamist käsitlenud uuringus 
leiti 112 kontroll rühma kuulunu hulgast 36-1 (32., 1%) vähemalt üks sugu­
haigus; 33-1 klamüdioos, kahel gonorröa ja ühel mõlemad haigused (süüfilist 
kontrollgrupi uuritavatel ei diagnoositud). Nimetatud uuringu oluliseks puudu­
seks on väike uuritute arv kontrollgrupis, mistõttu üldistavaid järeldusi on raske 
teha. Kuid ka olemasolevate tulemuste kohaselt esinesid nende käitumises 
statistiliselt tõepärased erinevused. Mõned kontrollrühma liikmetest võisid 
uuringus osaleda seoses eelneva kahtlusega, soovides uuringu raames läbida 
kontrolli suguhaiguste suhtes. Siiski tuleb arvestada, et klamüdioos kulgeb 
enamasti asümptomaatiliselt, mistõttu meie tulemused on olulised, ilmestamaks 
suurt hulka haigeid inimeste seas ning ennetavate skriiningprogrammide 
vajalikkust nende väljaselgitamiseks ja raviks. 
Traditsioonilistesse suguhaigustesse nakatumise tõus on Eestis seotud kõrge 
riskiga seksuaalkäitumisega: mitmed seksuaalpartnerid, juhuslikud seksuaal­
suhted (k.a juhuslikud seksuaalsuhted reisidel väljaspool Eestit), seksuaal-
vahekorrad alkoholijoobes. Mõlemas uuringugrupis (suguhaiged ja kontroll-
rühm) osalenute teadmised suguhaiguste levikuviisidest ja nende vältimis­
14 53 
võimalustest olid puudulikud, mis seab inimesed suguhaigustesse nakatumise 
ohtu. Enamus osalejaist teadis, et kondoom kaitseb suguhaiguste eest, siiski 
uskus 65%, et kaitset pakub suguelundite pesemine, 19,5% uskus seda suukaud-
setest rasestumisvastastest tablettidest. Alkoholi kuritarvitamine osalenute seas 
011 sage ning alkoholi kuritarvitajail oli rohkem seksuaalpartnereid, sh juhus­
likke (Tabelid 2, 3). 
Esimene HIV-nakkus registreeriti Eestis kümme aastat tagasi, 1988. aastal. 
1988-1999 püsis haigestumine stabiilselt madalal tasemel, kõikudes 
0,1/100.000 aastal 1988 kuni 0,6/100.000 aastal 1999. Kogu mainitud perioodi 
jooksul levis nakkus põhiliselt sugulisel teel, esimestel aastatel homoseksuaal­
selt, hiljem võrdselt homo- ja heteroseksuaalselt. Kaks esimest HIV-nakkuse 
juhtu veeni süstivatel narkomaanidel (VSN-del) diagnoositi 1997. ja 1998. a, 
sellele epideemilist levikut ei järgnenud. 
HIV/AIDS-i suurenenud leviku ohule viitas juba 1995-1996 ilmnenud 
kõrgenenud haigestumine B- ja C-hepatiiti, kuna levikuteed on ühised: ohtlikud 
süstimistavad, ühiste süstalde kasutamine. 2000. a. mais-juunis diagnoositi esi­
mesed viis HIV-nakkuse juhtu eeluurimisel viibivate kinnipeetavate VSN-de 
seas, nendest kolm oli Narvast. Augustis diagnoositi Narvas anonüümses 
VSN-del kabinetis kaheksa HIV-nakkuse juhtu. 
VSN-de arvu plahvatuslik tõus algas 1994.-1995. aja kestab tänaseni. Põhi­
line kontingent on heroiinitarbijad, valdavas enamuses vene keelt kõnelevad 
(ligi 90%), meessoost (85%), 15-25-aastased, oletatav arv kogu riigis 10 000-
12 000. 
Kokku registreeriti Eestis 2000. a jooksul 390 uut HIV-nakkuse juhtu (joo­
nis 2), sellest ligi 90% moodustasid VSN-d. 304 juhtu registreeriti Narvas, 
57 Kohtla-Järvel, 25 Tallinnas. 2001. aastal jätkus HIV-nakkuse epideemiline 
levik sama hoogsalt. Jaanuaris registreeriti 85, veebruaris 121, märtsis 170, 
aprillis 148 uut HIV-nakkuse juhtu. 2001. a levis nakkus Narvast teistesse Ida-
Virumaa linnadesse ja Tallinnasse (vastavalt 180, 188 ja 124 juhtu). Epidemio­
loogilised uuringud kinnitavad, et enim ohustatud on nooremad narkootikumide 
tarbijad, kes alles alustavad süstimist ja kasutavad ühte süstalt mitmekesi, jaga­
des ühte uimastiannust mitmele. 
Uuringus, mis käsitles süüfilise esinemist maakonniti seoses viis sotsiaal­
majandusliku näitajaga, leidsime statistiliselt tõepärased positiivsed korrelat­
sioonid süüfilisse haigestumise ning maakonna mitte-etniliste eestlaste 
(Pearsons r=0,509), linnaelanike osakaalu (Pearsons r= 0,524) ja tuberkuloosi 
haigestumuse (Pearsons r=0,444) vahel (selgitab süüfilisse haigestumuse 
varieeruvusest maakonniti vastavalt 25,9%, 27,5% ja 19,7%). Statistiliselt tõe­
pärase negatiivse korrelatsiooni leidsime süüfilisse haigestumise ja elussündide 
määra vahel (Pearsons p=-0,501). Seost töötuse ja tapmiste määra ning süüfi­
lisse haigestumise vahel meie uuringus ei ilmnenud (joonis 6, Tabel 4). Nimeta­
tud uuring käsitles unikaalset perioodi ühiskonna arengus, kus radikaalsed 
poliitilised ja majanduslikud muutused toimusid väga lühikese aja jooksul ning 
meil õnnestus ilmestada olulisi seoseid süüfilisse haigestumise ja ühiskonna 
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taseme näitajate vahel. Tulemused toetavad arusaama suguhaigustest kui 
sotsiaalsetest haigustest. 
Kokkuvõte 
Uuringu tulemused (suguhaigustesse nakatumist soodustavad kõrge riskiga 
seksuaalkäitumine ja puudulikud teadmised nende haiguste ennetamise või­
maluste kohta uuritute hulgas) tähtsustavad tervise- ja seksuaalkasvatuse laiema 
juurutamise oluliselt rahva tervise edendamises. 
HIV-infektsioon levis Eestis plahvatuslikult alles pärast nakkuse levikut 
veeni süstivate narkomaanide seas. Protsessi pidurdamiseks on vaja oluliselt 
tõsta VSN-de teadlikkust ennetusmeetmetest (süstalde vahetus, asendusravi, 
kondoomide kasutamine, koolitus-/nõustamisprogrammid). Äärmiselt tähtis on 
ka efektiivne suguhaiguste ravi, vältimaks HIV-infektsiooni laialdast levikut 
heteroseksuaalse elanikkonna seas. 
HIV/AIDS ja suguhaigused ei ole üksnes meditsiiniline, vaid ka riikliku 
tähtsusega sotsiaalne ja majanduslik riikliku tähtsusega probleem ning selle 
lahendamine on võimalik ainult juhul, kui võitlus AIDS-i, narkomaania ja 
suguhaigustega muutub riiklikuks prioriteediks, st liidetakse nii tervishoiu kui 
ka teised ühiskonna ressursid. 
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Summary: The present survey covers historical events in Estonia during the era of 
the USSR regime and the era after independence as regards incidence of sexually 
transmitted diseases (STDs). The diagnostical methods used as the reporting system 
are presented. Reasons for the increased incidence of traditional venereal diseases 
such as gonorrhoea and syphilis are discussed. The importance of migration of 
prostitutes from Russia is also considered. 
Keywords: STD, Estonia, historical factors 
INTRODUCTION 
Estonia, one of the Baltic states linked to the former 
USSR, regained its independence in 1991. The libera­
tion was followed by rapid and dramatic changes, 
especially in the fields of economics and politics. 
This led to destabilization and social disintegration, 
with great changes in old moral norms and increased 
prostitution. In most developed countries the 
incidence of conventional STD such as gonorrhoea 
and syphilis has rapidly declined during the last 15 
years'*. The development in Estonia, as in the other 
Baltic countries and in Russia, has been completely 
different During recent years the incidence of these 
STDs have increased rapidly. 
Data as regards frequency and distribution of 
STDs are limited for several reasons. All STDs are 
not classified as reportable. Syphilis, gonorrhoea, 
Chlamydia trachomatis infections, trichomoniasis 
and genital herpes simplex virus (HSV) infections 
are reportable diseases in Estonia. Data about the 
annual incidence of gonorrhoea and syphilis are 
available from early 1930s. However, misdiagnos­
ing and underdiagnosing are frequent and all new 
cases are not reported, especially if the diagnosis 
has been made by a gynaecologist or an urologist. 
The population of Estonia is approximately 1.5 
million and about one-third of the inhabitants live 
in the capital Tallinn, a seaport. The STD problem 
is especially concentrated to this area; in 1993 64% 
of new cases (240 cases) of syphilis and 50% of new 
cases (1783 cases) of gonorrhoea were reported 
from the Tallinn region3. In Estonia, like most 
western European countries, venereology is a 
Correspondence to: Dr A Uusküla, Department of Dermatology 
and Venereology, University of Tartu, Lossi str. 21/23, Tartu EE 
2400, Estonia 
subspecialty of dermatology. Currently about 70 
dermatologists are actively working in Estonia. The 
4 special clinics are in the biggest cities, including 
Tallinn and Tartu. According to old traditions 
patients with syphilis have been hospitalized. This 
habit has slowly started to change after the 
introduction of long-acting penicillins. However, 
new modes of treatment are not sufficient for 
breaking down old traditions. 
The diagnostics available and the procedure of use 
in Estonia are shortly presented in the following. 
During the USSR era the screening system for 
syphilis was entirely based on serological tests, 
mainly Wassermann complement-fixation (WR) test. 
All reported new cases with syphilis are and have 
been serologically verified. The tests available are as 
follows: the fluorescent treponemal antibody (FTA), 
the fluorescent treponemal antibody-absorption 
(FTA-ABS), the treponema pallidum haemagglutina-
tion-(TPHA) and treponema pallidum immobiliza­
tion (TPI) tests are used for verification and the WR 
and VDRL tests for screening purposes. The TPI test 
is performed only at the university clinic in Tartu. 
For diagnosing of bacterial STDs as gonorrhoea and 
chlamydia, microscopical and culture methods are 
used as routine tests. Different tests for antigen 
detection of Chlamydia trachomatis are available (DFA, 
ELISA). Culture diagnosis of chlamydia infections 
is carried out only in the central hospitals in Tartu 
and Tallinn. The diagnostic methods for viral STDs 
are restricted. Detection of HPV infections by use of 
PCR is carried out in cooperation between the 
University Clinic of Dermatovenereology and the 
Estonian Biocentre (mainly a basic science institu­
tion) in Tartu. The screening for HIV infection is 
carried out in the whole republic on a reliable level 
by the use of internationally accepted ELISA kits 
and verified by immunoblot. 
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THE CURABLE BACTERIAL SEXUALLY 
TRANSMITTED DISEASES 
Syphilis is a classical example of a STD which can be 
successfully controlled by public health measures1. 
After World War I and in the early 1930s the 
incidence of syphilis decreased in Estonia as in 
the other European countries, probably due to 
improved diagnostic tools, better treatment and 
control1. 
In Estonia the incidence of syphilis decreased 
rapidly during this period, from 122/100,000 new 
cases to 43/100,000 in 1933 and remained on a 
stable level until World War II4. The decrease in the 
incidence of syphilis is comparable with data from 
other European countries. During the same time 
period the annual number of new cases/100,000 
inhabitants in Sweden was lower than in Estonia, 
but a decline in incidence was observed5. 
During and after World War II a dramatic 
increase in the incidence of syphilis occurred. The 
total number of new cases in 1949 was 1642 (149/ 
100,000)4. After stabilization of the migration of 
ethnic groups and the economical situation in 
USSR and with the introduction of penicillin for 
treatment, the incidence of syphilis started to 
decrease. An improvement in disease control and 
partner notification system used became more 
effective during the same period. The annual 
incidence of new cases of syphilis remained stable 
(7/100,000) from 1959 to 1970 in Estonia4. A new 
increase of syphilis started and reached a peak in 
1976 (42/100,000)4. If this was a marker for 
changed sexual behaviour (delayed sexual revolu­
tion) or a consequence of intense national policy of 
forced migration within USSR still remains unclear. 
The Soviet health care system reacted with rather 
repressive measures of partner notification and 
compulsory treatment and the incidence of syphilis 
decreased again to 8/100,000 in 19824. All syphilis 
patients in Soviet Estonia were treated as in­
patients. 
From 1990 a constant increase of new cases has 
been recorded; 3/100,000 in 1990 and 56/100,000 in 
1994 (Figure l)4.-
The available data reporting the ratio of male to 
female new cases of syphilis during the last 25 
years is very constant, never exceeding 2:1 (Figure 
2).6 One possible interpretation to that can be the 
mainly heterosexual transmission route of syphilis 
(also gonorrhoea) in Estonia. The Estonian data 
differ from available data from Sweden, where the 
same ratio has constantly been much higher than 
2:1 during the same period1. 
In Estonia syphilis is most prevalent in young 
adults. In 1994,29% of women with verified syphilis 
were younger than 20 and 59% younger than 25. In 
1992 the corresponding figures were even more 
intriguing: 35% of the infected women were young­
er than 20 and 67% younger than 25. In 1994,44% of 
infected men were younger than 25 years and in 
1992, 52% correspondingly3. The sexual activity of 
these young people probably started during the 
period of great changes in the community. 
After many decades congenital syphilis was 
again diagnosed in 19933. 
Before World War II, from 1923 to 1935, the 
incidence of gonorrhoea varied on a level between 
280-351/100,000 (Hgure 3). In 1948 the incidence 
was 297/100,000 and thereafter a sharp decrease of 
annual reported cases took place. In 1951 the inci­
dence was 92/100,0004. The decrease was probably 
related to the general stabilization after the war and 
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Figure 2. Male to female ratio of reported syphilis cases in Estonia, 
1972-1994 
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Figure 1. Incidence of reported syphilis cases per 100,000 inhabitants 
in Estonia, 1923-1994 
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Figure 3. Incidence of reported cases of gonorrhoea per 100,000 
inhabitants in Estonia, 1923-1994 
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to introduction of penicillin as well as a reform in 
notification of partners. The situation remained 
stable until 1961, whereafter a steady increase in 
new cases of gonorrhoea started and from 1968 to 
1981 the annual incidence of new cases was steadily 
approximately 250/100,000 annually. Thereafter a 
steady decrease was recorded reaching a level of 
100/100,000 in 19884. It is of interest that a similar 
decrease started already in Sweden in 1972, in 
Finland in 1974 and in Norway in 1978. One reason 
for the prolonged high level of gonorrhoea was the 
routine use of penicillin or tetracyclines although 
gonococci rapidly developed resistance to these 
chemotherapeutics. One has to keep in mind that 
penicillin was used as an almost compulsory and 
only treatment in USSR. In a study carried out at 
the Department of Dermatovenereology, Univer­
sity of Tartu in 1994 it was found that 53% of 
isolated strains of Neisseria gonorrhoeae were B-
lactamase producing, an incidence remarkably 
higher than in Sweden (7%) or USA (9%)7. It is 
highly probable, that the uniform treatment of 
gonorrhoea and the use of drugs without prescrip­
tion in USSR resulted in a high incidence of 
antimicrobial non-B-lactamase resistance. 
During the last 15 years a sharp decrease of new 
cases of gonorrhoea has been observed in western 
Europe. In Sweden and Germany the current 
annual incidence of reported cases of gonorrhoea 
is approximately 10/100,000 and the majority of 
new gonorrhoea infections are imported to these 
countries2. The current epidemiological situation in 
these countries is partly a result of intervention 
programmes and partly due to changes in sexual 
behaviour as influenced by the existence of AIDS8. 
In Estonia the incidence of gonorrhoea is high and 
almost doubled from 128/100,000 in 1990 to 233/ 
100,000 in 19934. The marked increase again stresses 
how demographic, economic and political changes 
influence the pattern of STDs in a community. The 
decrease in incidence of new cases in 1994 and 1995 
can partly be explained by the introduction of 
quinolones and cephalosporines in the treatment 
and probably related to stabilization in the com­
munity, but may also be related to incomplete case 
reporting. As in the case of syphilis the male to 
female ratio has remained stable as regards 
gonorrhoea, during the last 20 years (Figure 4)6. 
According to available statistical data the majority 
of affected individuals of both sexes were younger 
than 30 years of age from 1991 to 1994. The 
difference between the 2 sexes could be observed 
only in the age group under 20, in which approx­
imately 40% more women than men were reported 
in both 1991 and 19923. 
Chlamydia trachomatis has been recognized as a 
genital pathogen during the last 25 years \ In Estonia, 
antigen detection methods for diagnosing chlamy­
dial infections become available in 1990 and C. 
trachomatis culture a few years later. No data as 
regards the true incidence of genital chlamydia in 
Estonia are available. The diagnosis was primarily 
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Figure i. Male to female ratio of reported gonorrhoea cases in Estonia, 
1976~199i 
made by venereologists in symptomatic cases. 
Almost two-thirds of the reported cases were men 
in 1991 and 19923. With increased screening of 
contacts and asymptomatic individuals the pattern 
has completely changed. In 1993 and 1994 over 80% 
of reported new cases were women3. In 1994, the 
total number of patients with genital chlamydial 
infection was approximately 4250 in Estonia and 
1994 was the first year when chlamydial genital 
infections outnumbered the reported new cases of 
gonorrhoea4. It is still too early to draw any 
conclusions regarding the true incidence of chlamy­
dial genital infections in Estonia. 
Trichomoniasis 
According to reported data Trichomonas vaginalis 
infections are the most prevalent STD in Estonia. 
The incidence has been high during the last 20 
years and has especially increased during the last 5 
to 6 years. The incidence in the whole population 
was 373/100,000 in 19944. Approximately 75% of 
the reported patients were women and the most 
affected age group is between 20-24 years3. 
In the Scandinavian countries trichomoniasis is 
not a reportable disease. But according to data 
obtained from visits to venereologists the incidence 
of this particular infection is low (approximately 
1% of new patients). 
SEXUALLY TRANSMITTED VIRAL 
INFECTIONS 
Genital herpes has been a reportable disease in 
Estonia since 1991. The diagnosis is frequently 
made clinically by exclusion of other reasons for 
genital ulcers. Antigen detection is so far restricted 
to a few centres. The true incidence of genital 
herpes in Estonia is still unknown, although the 
disease is rather commonly detected at STD clinics. 
Infections with HPV are not reportable in Estonia 
and no widely used screening system exist to 
detect this pathology (except Pap smears for 
women). In everyday practice this is not a rare 
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genital pathology among STD clinic patients, seen 
more commonly than genital herpes. 
HIV infection 
Until now HIV infections have rarely been dia­
gnosed in Estonia, despite appropriate screening 
with reliable methods. Since March 1996, 59 
seropositive cases have been reported. Presently, 44 
HIV-positive individuals live in Estonia and 4 of 
these have developed AIDS. Previously 2 persons 
have died due to AIDS and one HIV-positive patient 
has committed suicide. According to available data, 
21 of the HIV-positive individuals are homosexuals, 
10 bisexuals and 18 heterosexuals. Four women 
have been found to be HFV positive. Fifteen of the 
HIV-positive patients have a history of a previous 
syphilis infection. One-fifth of the HIV-positive 
patients are sailors8'9. 
DISCUSSION 
An increased incidence of STD is a characteristic in 
countries, such as the Baltic area, which have 
recently regained independence. In such areas 
political and socioeconomical changes occur simul­
taneously and an increase in prostitution develops 
rapidly. In Estonia, the number of tourists has 
increased rapidly, however, mainly from Scandina­
via, an area where the incidence of STD is low. The 
tourism from countries which belonged to 
the former USSR has decreased. One reason for the 
higher prevalence may therefore be the migration 
of prostitutes, especially from Russia. Other causes 
are probably connected with the dramatic changes 
within the society and a slowly responding medical 
service. 
The lack in economic equilibrium and insecurity 
have deepened in the society, and on the other hand, 
the freedom to make decisions has increased without 
a simultaneous consciousness of responsibility. In 
the former communist countries the physicians were 
responsible. Currently the population of Estonia is 
not prepared to feel responsibility for their personal 
health. This is especially true for patients with 
STDs. 
Estonia is gradually moving into a western-like 
society. However, one of the first steps has led to a 
rapid increase of prostitution and other forms of 'sex 
industry'. This type of problem is usually of 
economic origin. Young women without education 
have found an easy way to survive, but have no 
information on how to avoid catching an STD or 
avoid spreading STDs. This is an even more severe 
problem among migrating prostitutes and prosti­
tutes belonging to foreign ethnic groups. As 
prostitution is closely connected with criminal 
groups, the problem is difficult to solve. A further 
problem is the high number of prostitutes not using 
condoms. 
During the Soviet era contraceptives were 
equally unavailable. Abortion was the only method 
for family planning. Hence, the Estonian popula­
tion still does not recognize the importance of 
using condoms, not even in the case of casual 
intercourse. The importance and necessity of using 
condoms are continuously advertised on television, 
in newspapers and magazines. However, major 
response has still not been notified. 
In recently independent countries the economic­
al situation is problematic with a high inflation 
rate. In Estonia, as in the other former communist 
countries, the economical distress has had a 
negative impact on the health care system in 
general and on the preventive services specifically. 
Medical sevices do not receive sufficient financial 
support. Although the AIDS problem has been 
recognized by the government of Estonia, the funds 
directed towards preventing the spread of HIV 
infections have entirely been allocated to the 
specialists of infectious diseases, leaving the 
venereologists without economical support. There 
are also no laws for infectious diseases, which 
causes problems regarding contact tracing in the 
field of STDs. A further problem is a lack of 
sufficient services for patients with STDs. Although 
the number of specialists is sufficient, most of them 
are working entirely as dermatologists. The cen­
tralized venereal service system created during the 
USSR era does not fit in with the changed 
conditions. 
In conclusion, there was a 16 times increase in the 
incidence of new cases of syphilis during the period 
1991 to 1994. This dramatic change does not 
compare with changes in other STDs. One possible 
cause may be that medical care does not sufficiently 
reach patients with syphilis; some are afraid of 
hospitalization and some may be incorrectly 
diagnosed and treated by gynaecologists or urolo­
gists. One reason is probably the high migration of 
prostitutes from Russia, especially from St Peters­
burg, an area with a very high prevalence of 
infectious syphilis. It is essential to carry out further 
investigations in order to sort out changes in 
epidemiology as well as tracing risk factors 
currently present in Estonia. This is of special 
importance as HIV transmission often occur among 
patients with genital ulcers. 
Another question is, how reliable is the observa­
tion that the incidence of gonorrhoea has decreased 
during the last 2 years. Iltis phenomenon may be 
explained by the increases in use of single dose 
quinolones and cephalõsporines, which are also 
effective against B-lactamase producing gonococci. 
There may, however, be inaccurate data in the 
recording of new infectious cases. 
Contact tracing is not on an appropriate level, 
as the working venereologists see too many 
patients daily and in practice there is not sufficient 
time to deal with this crucial matter. There is an 
urgent need for a new legislation and additional 
funding allocated to improve the system in order to 
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make it more effective and improve the availability 
for STD patients to receive correct and fast 
treatment. 
It is also important to improve the cooperation 
between specialists in venereal diseases and specia­
lists in infectious diseases. Problems with STD and 
HIV infections cannot be solved separately. 
The major toor for dealing with viral STDs is 
prevention. The increased incidence of STDs is a 
marker of high-risk sexual behaviour, which 
creates a fertile soil for the spread of HIV infection. 
Further epidemiological studies regarding sexual/ 
health behaviour as well as improved information 
as regards STD are currently needed in Estonia, in 
order to create a more effective preventive 
system. 
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A case control study of patients at an STD clinic in Estonia found that individuals 
lacked adequate knowledge of disease transmission and that sexual behavior occurring 
during travel may contribute to disease rates. 
Abstract 
Background and Objectives. Epidemiologic data document rapidly increasing rates of 
STD throughout Eastern Europe. 
Goal of this Study. This case-control study was designed to delineate factors 
contributing to the STD epidemic in Estonia. 
Study Design. One hundred eighty-nine cases and 112 controls completed a behavioral 
questionnaire and were tested for Neisseria gonorrhea, Chlamydia trachomatis, and 
Treponema pallidum. 
Results. STD prevalence among controls was 32%. Although participants believed that 
condoms prevent STDs, only 17% reported consistent use. Methods believed to prevent 
transmission included washing the genitals (65%), urinating (26%), douching (35%), 
and using oral contraceptives (19%). An interaction between sex and travel outside of 
Estonia (OR = 0.1, 95% CI = 0.0-0.7) reflects that males with STDs were more likely to 
report travel (46% cases, 45.5% controls with STD) than were those without STD 
(16.1% controls without STD). 
Conclusion. STD rates are related to high-risk sexual behavior among males while 
traveling outside of Estonia. Intervention is needed to promote understanding of disease 
transmission dynamics in this area and to decrease sexual risk behavior, particularly in 
the context of travel. 
Concomitant with the cessation of communist rule in 1991, the Baltic countries of 
Latvia, Estonia, and Lithuania have experienced a tenfold increase in rates of sexually 
transmitted disease (STD).1 For example, in Estonia, incidence rates of syphilis have 
increased from 3 to 75.7 per 100,000 between 1990 and 1998 (Source: Estonian 
Ministry of Social Affairs, 10/2000). In addition, although there were relatively low 
rates of HIV infection in this country until last year, there has recently been a dramatic 
increase in the number of cases. At the end of 1999, the World Health Organization 
reported that there were only 50 known persons with HIV living in Estonia. However, 
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in 2000 an outbreak occurred in western Estonia, resulting in the report of over 
300 cases to Estonia's mandatory State Health Protection Service.2 Injection drug use 
(IDU) was posited to be a major contributing factor to this outbreak, as it has been 
throughout Eastern Europe.3"4 
Several factors are likely to contribute to the increasing rates of STD/HIV infection 
in Estonia. First, the country borders the Russian Federation, where drug use, high rates 
of STD, economic instability, and low knowledge of disease transmission dynamics 
have been linked to a 100-fold increase in newly identified HIV infections between 
1996 and 1998.5 In this same time period, 3 to 175-fold increases in syphilis occurred in 
Eastern European and Central Asian countries,6-7 with a prevalence rate among 
pregnant women of 710 per 100,000 in the Moscow region in 1997.8 It has been posited 
that the increased mobility of populations across borders, in conjunction with a 
changing economic climate and shift toward a more western culture may make certain 
risk behaviors, such as trading sex for money and engaging in casual sexual 
relationships, more prevalent in Estonia and the other Baltic countries.9-10 
Changes in the political and economic environment in Eastern Europe have also 
been associated with changes in the control of STDs. A highly developed system of 
surveillance for STDs was developed during the Second World War. At that time, there 
was active compulsory case finding and screening of certain occupational and clinical 
populations. The STD control system since the breakup of the Soviet Union has been 
characterized by serious shortfalls in funding, decentralization, and increased demand 
for confidentiality. Additionally, medications previously provided free must now be 
purchased.11 These changes have been mirrored in former Soviet states such as 
Estonia,12 and have clearly impacted the medical system's ability to track epidemics and 
to identify and treat patients with STD. 
Although the prevalence of HIV in Estonia is still low overall, rising STD rates and 
drug use, coupled with increasing travel across borders to areas with higher HIV 
prevalence, could create the conditions for an HIV epidemic throughout the country. 
Irrespective of the changes occurring in the health system, little systematic research has 
been conducted to ascertain which risk behaviors are most closely associated with the 
evolving STD /HIV epidemic in these areas. In addition, there has not been adequate 
investigation into knowledge regarding disease transmission within this population. The 
current study seeks to identify predictors of STD acquisition in Estonia and to provide 
further insight into the factors that may be responsible for the increase in their 
incidence. 
Materials and Methods 
Respondents. Study activities took place at the Tartu University Clinic of Dermato-
venerology. The medical school is the only one in Estonia, and the STD clinic is the 
second largest in the country. A case control methodology was used. Between 9/96 and 
6/98, 301 men and women over the age of 18 were recruited for study participation. 
Cases were composed of all participants who presented for care to the clinic of 
Dermatovenerology with a diagnosis of Chlamydia trachomatis, Neisseria gonor­
rhoeae, or Treponema pallidum. Of the 229 clinic registrants approached for study 
participation, 189 were enrolled as cases. 
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Controls were selected at random from the regional population registry. Each 
participant selected was sent a letter describing the study and requesting them to contact 
study representatives at Tartu University. The letter included information that the study 
would involve an STD examination. A total of 1,100 letters were sent from the registry, 
and 112 persons responded and were enrolled as controls. Controls were further divided 
as a function of their STD status at the time enrollment. Demographic information 
derived from the registry revealed no statistically significant differences between those 
recruited and those declining participation as a function of their documented sex, 
marital status, or education. 
Procedures. All patients who engaged in the study were asked to complete a self-
administered questionnaire, after providing informed consent for their participation. 
Items included in the questionnaire were developed in English with the input of STD 
health care providers in Estonia, translated into Estonian and Russian, and piloted on a 
sample of 10 clinic patients. All study procedures were approved by the Institutional 
Review Board at SUNY Downstate Medical Center and by the Ethics Board at Tartu 
University. 
Participants were asked to report on their lifetime history of STD diagnosis prior to 
study entry, drug use, and of paying for sexual activity. The prevalence of alcohol-
related problems was determined via the four-item CAGE questionnaire.13 Respondents 
also answered a series of questions on behavior in the last 3 months, including whether 
they had been sexually active, had greater than three sexual partners, used condoms 
consistently (always or almost always), engaged in sexual activity while drunk, offered 
money to someone in exchange for sex, had a casual sexual partner, engaged in anal 
sex, and whether they had used illicit drugs. Additional questions focused on whether 
respondents believed that their current sexual partners had other sexual partners in the 
last 3 months and whether they had traveled outside of Estonia in the past year. Finally, 
ratings were conducted on beliefs regarding STD prevention. The perceived efficacy of 
different activities in preventing the transmission of STD was assessed on three-point 
scales (ineffective, effective, don't know). Items included washing the genital area after 
having sex, urinating after sex, condom use, douching after sex, and using birth control 
pills. 
All participants received an exam in which cervical or urethral cultures were 
obtained for Neisseria gonorrhoeae and Chlamydia trachomatis. Specimens for 
gonorrhea were plated on Thayer-Martin medium (Nouva Aptaca srl, Italy). Cultures for 
chlamydia were performed using McCoy cell monolayers (European Collection of Cell 
Cultures, Salisbury, UK). In addition, syphilis serologic status was determined using the 
rapid plasma reagin test with Treponema pallidum with FTA for confirmation. 
Statistical analysis. Demographic and behavioral variables were compared across 
groups (i.e., cases, controls with STD, controls without STD) using the Fisher exact test 
for dichotomous variables and t-tests for continuous variables. Beliefs about STD 
transmission were compared across groups using likelihood ratio chi-square tests. Odds 
of having an STD associated with engaging in a series of sexual risk behaviors were 
estimated among those who reported sexual activity in the last 3 months via logistic 
regression models, with group and sex included as main effects and a product term 
included to assess moderator effects. Demographic and behavioral factors that 
differentiated group membership based on these analyses were selected for inclusion in 
a multinomial logistic regression model. 
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Results 
Participant characteristics. Of the total study participants, 225 (74.7%) tested positive 
for Chlamydia trachomatis, Neisseria gonorrhoeae, or Treponema pallidum. Among 
the 189 cases, 71% were positive for chlamydia, 24.1% for gonorrhea, and 25% for 
syphilis. Among cases, 15 were positive for gonorrhea and chlamydia, 11 for syphilis 
and chlamydia, 1 for syphilis and gonorrhea, and 1 for all STDs. Among the 
112 controls, 36 (32.1%) were positive for at least 1 STD; 33 for chlamydia, 2 for 
gonorrhea, and 1 for gonorrhea and chlamydia. No controls were positive for syphilis. 
Controls with STD were more likely to test positive for chlamydia than were cases 
(94.4% versus 71.0%, g < .05), and less likely to test positive for gonorrhea (8.6% 
versus 24.1%, g < .05). 
Respondents ranged in age from 18 to 57 (Mean = 26.5, SD = 6.4). A small majority 
of respondents were female (56.7% versus 43.3% male). Cases tended to be younger 
than controls; 67.5% of these fell below the median age of 25, as opposed to 50.0% of 
controls who presented with an STD and 36.6% of controls who were not positive for 
an STD (g < .05). Approximately half (54.0%) of the participants included in the study 
were either married or living with a sexual partner. Sixty-two percent of the sample was 
employed, and 29.2% reported that they were currently going to school. Most of the 
population (80.7%) reported that they were Estonian, and 15.9% reported a Russian 
background. A history of drug use was reported by 15.1% of the entire sample, with 
6.6% reporting drug use in the past 3 months. The drugs reported by those who had 
used in the past 3 months included marijuana (n = 6), cocaine (n = 4), and ampheta­
mines (n = 6). Injection heroin use was reported by 1 respondent, who also reported 
using ketamine. The prevalence of a clinically significant CAGE score was 35.2% 
across the entire sample. There were no statistically significant differences between 
cases, controls with STDs, or controls without STDs in terms of sex, marital status, 
employment rates, drug use history, or CAGE scores. 
Beliefs about STD prevention. Both cases and controls held misperceptions about 
methods for preventing the transmission of STDs, although there were no statistically 
significant group differences in terms of level of knowledge. Across the entire sample, 
65.2% believed that washing the genital area after sex is an effective means for 
preventing STD (6.3% reported that they did not know), 25.7% believed that urinating 
afterwards is effective (35.8% did not know), 35.5% believed that douching is effective 
(43.8% did not know), and 19.5% believed that using birth control pills is effective 
(22.2% did not know). Most of the participants believed that condoms are effective for 
STD prevention (94.5%); 3.1% claimed that they were unsure about their efficacy. 
Univariate behavioral associations with group membership. Across all groups, 
respondents reported that they had recently engaged in a series of sexual behaviors 
(Table 1). In logistic regression models, there was a main effect of group membership 
after controlling for sex across several behaviors, including the proportion who reported 
(1) having a previous STD diagnosis (58.1% cases; 26.5% controls with STD; 40% 
controls w/o an STD), (2) having three or more sexual partners in the last 3 months 
(21.0% cases; 5.7% controls with an STD; 8.5% controls without an STD, p < .05), (3) 
having a casual sexual partner in the last 3 months (43.0% cases; 20.6% controls with 
an STD; 20.3% controls without an STD, g < .05), and (4) engaging in sexual activity 
while intoxicated from alcohol (67.4% cases; 48.5% controls with an STD; 43.1% 
controls without an STD, g < .05). In turn, respondents who reported engaging in sexual 
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activities while intoxicated were more likely to report that in the last 3 months they had 
been inconsistent condom users (86.3% versus 76.4%, g = .055), to have had three or 
more sexual partners (25.9% versus 6.4%, p < .05), to report a casual sexual relationship 
(52.6% versus 19.6%, p < .05), and to have solicited sexual activity (7.8% versus 1.1%, 
g < .05). There were no group differences detected in the proportion reporting lifetime 
drug use, a high CAGE score, travel outside the country in the last year, abstinence in 
the last 3 months, a belief that the respondent's sexual partners had concurrent sexual 
relationships in the last 3 months, paying for sexual activity in the last 3 months, and 
always or almost always using condoms in the last 3 months. 
There were main effects of sex after adjusting for group membership for (a) lifetime 
drug use (22.7% males; 9.5% females, g < .05), (b) CAGE scores denoting alcohol 
problems (56.9% males; 18.8% females, g < .05), (c) three or more sex partners in the 
last 3 months (30.2% males; 5.4% females, g < .05), (d) prevalence of a casual sex 
partners in the last 3 months (50.8% males; 22.3% females, g < .05), (e) being 
intoxicated during sexual activity (69.4% males; 51.6% females, g < .05), and (0 paying 
for sex in the last 3 months (10.5% males, 0% females, g < .05). 
Product terms were computed between sex and group membership for each behav­
ior. The interaction predicting travel outside of Estonia in the last year approached 
statistical significance (g = .07), such that males with STDs were more likely to report 
travel in the past year (46% cases, 45.5% controls with STD) than were those without 
STD (16.1% travel for controls without STD). These differences were not seen among 
women (32% cases, 36% controls with STD, 31.8% controls without STD). Sexual 
relationships with new partners while traveling in the last year were reported by 16.1% 
of male cases, while none of the controls reported this behavior. 
Multivariate behavioral associations with group membership. A multinomial logit 
model was conducted to assess for group differences as a function of age, STD history, 
travel, casual sexual partners, having three or more sexual partners, sexual activity 
while intoxicated, and sex (Table 2). A product term representing the interaction of sex 
and travel significantly increased the fit of the model, and was also included 
(x2 difference = 6.9, df = 2, g < .05). The resulting equation was statistically significant 
(x2 = 53.1 (16), g < .05), with age, lifetime history of an STD, sexual intercourse while 
intoxicated, and the product term of sex and travel differentiating the groups. In terms of 
age, those less than the median age of 25 were significantly more likely to have an STD 
than were controls without an STD (OR = 3.3, 95% CI = 1.7 - 10.0), and controls with 
an STD (OR = 3.3, 95% CI = 1.5 - 10.0). Individuals who reported an STD diagnosis 
prior to study entry were over four times more likely to be cases then to be controls with 
an STD (OR = 4.2, 95% CI = 1.6 - 11.2). The only sexual behavior that differentiated 
group membership after controlling for other factors in the model was whether the 
respondent had engaged in sexual intercourse while intoxicated. Those engaging in this 
behavior were three and a half times more likely to be cases than to be controls without 
an STD (OR = 3.5, 95% CI = 1.6 - 7.6). Finally, after controlling for all other variables 
in the multivariate model, there was a statistically significant interaction detected 
between having traveled outside of Estonia by sex of the respondent for the comparison 
of cases versus controls without STD (OR = 0.1, 95% CI = 0.0 - 0.7), and a trend 
toward statistical significance for the comparison of controls with STD versus controls 
without STD (OR = 0.1, 95% CI = 0.0 - 1.0). These interactions reflect the greater odds 
of STD among males who traveled (OR = 4.4, 95% CI = 1.5 - 16.0). 
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Conclusions 
Increased rates of STD in Estonia are associated with patterns of sexual risk behaviors 
typical of STD epidemics in countries with similarly shifting political and social 
climates. Foremost, travel outside of Estonia among men was associated with risk for 
STD. Travel was also a marker for engaging in casual sexual relationships, in sex in 
exchange for money, and for sexual activity with a new partner while traveling. This 
suggests that sexual risk taking outside of the country may increase the likelihood of 
exposure to disease and subsequently increase the pool of infected persons within the 
region. Further investigation into the sexual health of travelers may yield important 
insights into STD transmission in this population. 
Cases and controls exhibited similarly high levels of misconceptions regarding 
methods for preventing disease transmission. Although this population was generally 
aware that condom use is an effective prevention tool, over 65% believed that washing 
the genital area is effective, and between a fifth and a third of the population believed 
that using birth control pills, douching after intercourse, or urinating after intercourse 
are also effective. Incorrect knowledge regarding these issues may place individuals at 
increased risk for HIV/STD if they rely on these behaviors for disease prevention; 
education regarding the efficacy of different modes of disease transmission and 
prevention is important in this population. 
Those who reported recent alcohol intoxication during sexual intercourse were more 
likely to be cases than to be controls testing negative for STD. Individuals reporting this 
behavior were also more likely to have multiple and casual sexual partners, to have 
engaged in sex exchange behavior, and were less likely to report using condoms consis­
tently. It may be the case that a variable such as reporting engaging in sexual activity 
while intoxicated may be a marker for a behavioral style that is more risky overall (as 
opposed to this behavior playing more of a causal role in STD transmission). However, 
these findings, when coupled with the fact that over a third of the population had a 
CAGE score that indicating alcohol-related problems, suggest that identification and 
treatment of alcohol addiction may be an important component of disease control in this 
population. Further study is needed to ascertain the precise relationships between these 
variables. 
Low rates of drug use may help explain why there has been a low impact of HIV in 
this area. Fewer than 7% of respondents reported any recent drug use, and only 1 
reported injection drug use. In the neighboring Russian Federation, however, the 
UNAIDS has estimated that the proportion of HIV infections has nearly doubled from 
the end of 1997 to the end of 1999, and that nearly all of these infections were 
attributable to injection drug use.14 Given increased travel between these regions, drug 
use prevention may be an important tool in preventing an epidemic of HIV infection in 
Estonia. 
Although other sexual risk behaviors did not differentiate between cases and con­
trols with and without an STD, there are several findings that warrant further attention. 
First, despite the fact that almost all respondents were aware that condom use protects 
against STD, less than one-fifth reported always or almost always using condoms. 
Second, the 32% STD prevalence rate among those recruited into the study as controls 
indicates that improved disease identification and treatment is warranted. Those 
individuals with STD in the control group were more likely to have chlamydia, and less 
likely to have had gonorrhea or syphilis. Given that symptoms of chlamydia are often 
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less noticeable than these other diseases, it may be that many of these individuals were 
probably unaware of their disease, rather than avoiding treatment for a suspected 
condition. These findings suggest that this population may benefit from efforts aimed at 
greater outreach and screening, coupled with sexual risk reduction counseling. 
Several limitations to the data exist. First, given the low rate of response from the 
mail recruitment of controls, coupled with the extremely high rate of STD among this 
group, it is likely that some bias exists in this group. For instance, our letter of invitation 
explicitly stated that an STD examination would be provided as part of study activities. 
Thus, controls who responded to this letter may have done so because they were 
explicitly seeking STD care for an extant symptomatic condition. For these reasons, the 
STD prevalence rate among controls is likely to over-represent the true rate of infection 
in this group. Similarly, differences reported in risk behavior and cognitions may be 
attributable to sample selection, such that those with suspected conditions were more 
likely to differ than those without. These methodological concerns are often inherent in 
a case-control study such as this one. Given that there were still statistically significant 
behavioral differences between the cases and controls, however, this supports rather 
than detracts from the contention that these two groups are fundamentally different. A 
second issue relates to the relatively low sample size in the study. The smaller number 
of participants may have resulted in a decreased power to detect differences of interest, 
particularly as they relate to moderating relationships. Clearly, further research with a 
larger and more representative sample would help support the validity of the cognitive 
and behavioral differences found between cases and controls in this study. 
The epidemic nature of STDs currently documented in Estonia and the other Baltic 
countries is consistent with our findings demonstrating high rates of sexual risk 
behavior and inadequate knowledge regarding prevention of disease transmission. It is 
important to note that the rise in STDs in the region, although quite dramatic, is also 
very recent. These factors signify that basic health education and promotion efforts 
implemented across the entire population should be a public health priority, particularly 
now while rates of HIV within this area are still low. 
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Table X. Univariate logistic regressions predicting behavior as a function of group and sex. 
Cases (%) Controls w/o Controls w/ STD 
(N= 189) STD (%) (%) 
(N = 76) (N = 36) 
M F Total M F Total M F Total 
Lifetime history of STD * 55.2 60.6 58.1 29.0 47.7 40.0 27.3 26.1 26.5 
Lifetime history of drug use t 24.4 12.0 17.7 19.4 6.8 12.0 18.2 4.0 8.3 
CAGE score indicative of alcohol 56.8 19.8 37.0 64.5 18.2 37.3 36.4 16.0 22.2 
problems t 
Travel outside Estonia in the last 46.0 32.0 38.5 16.1 31.8 25.3 45.5 36.0 38.9 
year $ 
Abstinent last 3 months 9.3 9.0 9.1 20.7 16.7 18.3 27.3 12.5 17.1 
Three or more sexual partners last 34.9 9.0 21.0 20.7 0.0 8.5 18.2 0.0 5.7 
3 months * t 
Sexual relationship with a casual 56.3 31.3 43.0 40.0 6.8 20.3 36.4 13.0 20.6 
partner last 3 months * f 
Sexual activity while intoxicated on 77.4 58.5 67.4 50.0 38.5 43.1 54.5 45.5 48.5 
alcohol last 3 months * t 
Believes partner(s) had other sexual 17.7 20.2 19.2 9.5 15.8 13.6 0.0 21.1 15.4 
relationships last 3 months 
Paid for sexual intercourse last 13.1 0.0 6.0 3.4 0.0 1.4 9.1 0.0 3.0 
3 months t 
Always used condoms last 3 months 18.8 21.3 20.1 4.2 18.4 12.9 0.0 15.0 10.7 
* E < .05 main effect of group membership 
t e < .05 main effect of sex 
t E = .07 interaction of sex * group 
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Table 2. Multinomial logit model regressing group membership onto sexual risk behaviors. 
Cases vs Cases vs Controls w/ 
Controls w/o Controls w/ STD vs 
STD STD controls w/o 
STD 
Chi-square OR 95% CI OR 95% CI OR 95% CI 
(all df=2) 
Male 0.3 1.2 0.6-2.6 1.2 0.5-3.2 1.0 0.3-2.7 
Age greater than 25 15.5 * 0.3 0.1-0.6 0.3 0.1-0.7 1.0 0.4-2.6 
Travel outside Estonia in last year 1.4 1.5 0.7-3.2 0.8 0.3-2.0 1.8 0.6-5.1 
Three or more sexual partners; 0.7 0.6 0.1-2.5 1.4 0.2-9.0 0.4 0.0-3.9 
3 months 
Sexual activity while intoxicated; 10.1 * 3.5 1.6-7.6 1.5 0.6-3.8 2.3 0.8-6.5 
3 months 
Sexual relationship with casual 3.0 2.1 0.7-6.4 2.1 0.6-7.2 1.0 0.2-4.4 
partner; 3 months 
Ever been diagnosed with an STD 9.8* 1.6 0.7-3.3 4.2 1.6-11.2 0.4 0.1-1.1 
Travel * Male sex 6.9* 0.1 0.0-0.7 1.1 0.2-6.8 0.1 0.0-1.0 
* P < .05 for the overall parameter estimate. 
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Summary: Sexually transmitted infections (STTs) are considered a major public 
health problem, globally. In particular, increasing STI rates have been documented 
throughout eastern Europe and central Asia. The Russian Federation and adjacent 
countries have, traditionally, managed STIs on an aetiological basis. This approach 
is expensive in terms of laboratory costs and it may lead to delayed diagnosis and 
treatment. To overcome the limitations of the aetiological management of STIs, the 
World Health Organization (WHO) has placed an increased emphasis on integrated 
care using syndromic management at the primary care level, especially in 
developing countries. This article reviews the current aetiology of STIs in Estonia, 
an eastern European country bordering the Baltic Sea and formerly a part of the 
Soviet Union, with the aim of defining whether infection with Trichomonas vaginalis 
is common enough to include its management in a syndromic management 
protocol. The use of syndromic management, in general, is also discussed. 
Keywords: Sexually transmitted infections, syndromic management, trichomoniasis, Estonia 
INTRODUCTION 
Sexually transmitted infections are considered a 
major public health problem, globally. HIV and STI 
epidemics have had remarkable social, demo­
graphic and economic consequences in Africa and 
Asia. Since the 1990s, there has been a dramatic 
increase in the reported incidence of STIs in eastern 
Europe and central Asia1. Despite under-reporting 
of cases and a decline in mass screening, an 
epidemic has been documented2'5. 
The Russian Federation and its adjacent countries 
have, traditionally, managed STIs on an aetiological 
basis, i.e. the diagnosis is made first before treatment 
is given. This approach is expensive because of 
physician, laboratory and consumable costs, it may 
also lead to delay in diagnosis and treatment and 
might carry the risk of stigma if the clinic is 
designated as an STI clinic3. Economic difficulties, 
market reforms and political restructuring have 
had a detrimental impact on the healthcare system. 
Medical services have not received sufficient 
financial support4-5 and limited resources have 
led to a situation where specialist SH services are 
Correspondence to: Anneli Uuskiila. Clinic of Dcrmatovenereology, 
University of Tartu, Lossi st. 21/23, Tartu 51003, Estonia 
E-mail: annskla@ut.ee 
available to a minority only, i.e. those who can pay 
(in some regions) or urban residents near centres 
with laboratory support1. To overcome the limita­
tions and the expense of aetiological management 
of STIs, the WHO emphasizes an integrated 
primary care approach using syndromic manage­
ment. The advantages of this might be prompt 
care and cost saving, with increased patient 
satisfaction. However, the syndromic approach is 
of limited use in those with poor treatment-seeking 
behaviour and is only applicable to patients with 
symptomatic infection6. Further, while it may be 
useful in the management of urethritis and genital 
ulceration, its value is less well proven for the 
management of vaginal discharge. In addition, the 
epidemiology of STIs may vary from country to 
country, even within the same region7. These 
differences may reflect a variety of social, cultural 
and socioeconomic factors including access to 
appropriate treatment8. In order to maximize the 
value of the syndromic approach the prevalence 
of the various STIs and their susceptibility to 
antibiotic treatment needs to be known6-9. 
This article reviews the current epidemiology of 
STIs in Estonia, an eastern European country 
bordering the Baltic Sea and formerly a part of 
the Soviet Union. The aim is to define whether 
infection with T. vaginalis in men is common 
21 
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enough to indude its treatment in a syndromic 
management protocol. The use of syndromic 
management, in general, for the management of 
STIs is also discussed. 
INCIDENCE AND TRENDS OF STIs 
IN ESTONIA, 1988-1999 
Epidemiological information about STIs in Estonia 
is derived from notification of cases and epidemio­
logical studies. Syphilis, gonorrhoea, trichomoniasis, 
chlamydial infection, genital herpes and anogenital 
wart virus infections, as well as HIV infection are 
all notifiable to the Health Protection Inspectorate 
and this is a mandatory obligation on physicians. 
However, all STI surveillance systems under­
estimate the prevalent caseload since not all 
infections are reportable and many patients with 
STIs are asymptomatic and, therefore, do not seek 
care. Because of the continuing public perception 
of social stigma associated with the acquisition of 
an STI, many patients do not seek care at all and, 
even if they do, as elsewhere in the world, 
misdiagnosis may occur and infections may not be 
reported because of this. Despite these well known 
problems, and a decline in the mass screening 
which used to take place during the Soviet era, the 
incidence of reported STIs increased during the 
early 1990s (Figure 1), the most dramatic rise being 
in new cases of syphilis where the prevalence 
increased between 1990 and 1998 from 3.3 to 75.7 
per 100,OOO10. The prevalence of gonorrhoea almost 
doubled between 1990 and 1993 (the first years of 
independence in Estonia) from 128 to 233 per 
100,OOO10. Antigen detection methods for diagnosing 
genital infection as Chlamydia trachomatis became 
available in 1990 with culture coming on line a few 
years later. The reported number of new cases of 
chlamydial infection exceeded that of gonorrhoea 
for the first time in 1994. In 1995, the prevalence 
of chlamydial infections was 364 per 100,000 
population10. 
Infection with T. vaginalis is the most prevalent 
non-viral STI in Estonia. The incidence has been 
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Figure 1. Reported incidence of sexually transmitted infections in 
Estonia 1988-1999 
high over the last 20 years and showed an increase 
in the beginning of 1990s. In 1996, the reported 
incidence was 400 per 100,000 population, being 
the leading STI for men (Figure 2), and frequent 
cause of male urethritis (Figure 3). In recent years, 
however, the reported number of infections has 
declined10. Genital herpes has been reportable since 
1991. The diagnosis is frequently made on clinical 
grounds and antigen detection is, so far, restricted 
to only a few centres. The incidence of neonatal 
herpes infection is estimated to be approximately 
one per 4000 deliveries11. A seroprevalence study, 
conducted in the years 1996-1997 showed that 
12.7% of pregnant women had herpes simplex 
virus (HSV-2) antibodies and 36.1% had antibodies 
to human papillomavirus (HPV-16)12. 
The incidence of HIV infection in Estonia has 
remained low. Since 1988, 334 cases have been 
identified with a male to female ratio of 274/6014. 
The available data on those tested for HIV infection 
indicate that the high-risk groups in Estonia are 
injecting drug users, patients with other STIs and 
sailors1^-15. 
DIAGNOSIS OF STIs IN ESTONIA 
Syphilis is diagnosed both clinically and in the case 
of a primary chancre by dark ground examination 
of secretions from the lesion for identification of 
Treponema pallidum. All cases, whether associated 
with clinical infection or not, are confirmed using 
serological tests. Blood is screened using either 
the rapid plasma reagin (RPR) test or the 
Venereal Diseases Reference Laboratory (VDRL) 
test. Confirmation is with the Treponema pallidum 
haemagglutination assay (TPHA) and/or the fluor­
escent treponemal antibody-absorbed (FTA-Abs) 
test. Detection of chlamydial infection is by one of 
the antigen detection methods such as enzyme 
immunoassay (EIA) or indirect fluorescent antibody 
(IFA) test and, where available, deoxyribonucleic 
acid (DNA) amplification tests such as the ligase 
chain reaction (LCR) or polymerase chain reaction 
(PCR). These latter tests are not widely available 
350 
I 300 
250 
206 
200 
151 r 150 
100 
83.7 
62.7 77 2 ! 72.1 
>5.2 
1988 1992 1990 1994 1990 1998 
-£> Gonorrhea -»-Syphili« -«-Trichofnofiiasls Chlamydial« 
Figure 2. Reported incidence of sexually transmitted infections in men 
in Estonia 1988-1997 
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Figure 3. Proportions of reported cases of sexually transmitted 
infections causing urethritis in men in Estonia 1988-1997 
due to their high cost. Gonorrhoea is diagnosed on 
microscopy of a Gram-stained smear of genital 
secretion and by culture on a selective medium. 
Trichomoniasis is identified on microscopy of a wet 
preparation and by culture (using Trichomonas 
Medium No. 2, Oxoid Ltd, UK), taken from the 
urethra. Genital herpes has been a reportable 
disease in Estonia since 1991. The diagnosis is 
frequently made clinically by exclusion of other 
reasons for genital ulcers. Antigen detection is 
restricted, so far, to a few centres and identification 
by culture method is not available in Estonia. The 
true incidence of genital herpes in Estonia is still 
unknown, although the disease is rather commonly 
detected at STI clinics. 
Detection of HIV antibodies in Estonia is through 
the use of internationally accepted enzyme-linked 
immunosorbent assay (ELISA) kits and positive 
results are verified by immunoblot. 
ANALYSIS OF STI DATA REPORTED 
TO THE HEALTH PROTECTION SERVICE 
IN THE TARTU DISTRICT 
Tartu is the second largest city in Estonia with a 
population of approximately 100,000. The popula­
tion of Tartu District (including Tartu city) is 
150,000. Tartu University has the only medical 
school in the country. Each district in Estonia has a 
Health Protection Service, which collects data 
about notified cases of STIs from all medical 
facilities in its locality. Until 1998 the data included 
a patient's personal identification number. We used 
this to find out people with several concomitant 
infections and/or persons with frequently diag­
nosed STIs. In 1998, in Tartu city and its district, 
1558 cases of STIs were reported from 19 different 
medical facilities. The male to female ratio was 
41:59. There were 61 cases of syphilis, 92 cases of 
gonorrhoea, 386 cases of trichomoniasis, 673 cases 
of chlamydial infection, 90 cases of genital herpes 
and 256 cases of anogenital wart infection. Of these 
1558,1387 cases (1219 individuals) were eligible for 
further analysis of concomitant infections. In other 
cases (171), some digits of patient's personal 
identification number, needed for identifying 
people, were missing. 
In 1998, 46 females (5.8%) and 74 males (17.6%) 
were reported to have co-infection with at least 2 
different STIs during the same clinical episode. The 
most frequent combination was, in women, co-
infection with C. trachomatis and T. vaginalis (36%). 
In women with more than one infection, T. vaginalis 
was found in 56% of cases (Figure 4). In men, tricho-
monal infection was accompanied by chlamydial 
infection in 28% of cases and by genital wart virus 
infection in 16% of cases. In men with more than 
one infection, T. vaginalis was found in 59% of cases 
(Figure 4). 
Co-infection with C. trachomatis and Neisseria 
gonorrhoeae was found in only 9 patients (0.7% of all 
patients) and the detection of more than 2 STIs, 
simultaneously, was very rare (13 patients, 1.1% of 
all persons with STIs). Of those with more than 2 
infections 85% were men. Two point nine per cent 
of patients with proven STIs had repeated episodes 
within the same year. 
Finally, all medical facilities are supposed to 
report their data to the Health Protection Service. In 
spite of that, in Tartu city and its district, 98% of 
cases of syphilis, 90% of gonorrhoea cases and 97% 
of those notified with genital wart virus infection 
were reported from the University STI Clinic. 
Furthermore, 96% of cases of trichomoniasis in 
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Figure 4. Combination of sexually transmitted infections. 
CT=chlamydiosis, TV-trichomoniasis, HPV=anogcmtal HPV 
infection, CC=gonorrhoea. GH=genital herpes, SY=syphilis 
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meri and 97% of cases of chlamydiosis in men were 
reported from the University STI Clinic. 
DISCUSSION 
Sexually transmitted infections have significant 
complications and social stigma associated with 
them. Pelvic inflammatory disease, ectopic preg­
nancy and tubal infertility are well recognized 
complications of chlamydial and gonococcal infec­
tions but some STIs may influence the risk of still 
birth, preterm labour and can affect the neonate3. In 
Estonia, the ectopic pregnancy rate is high and has 
increased from 11 to 16 per 1000 pregnancies 
between 1990 and 199616. Local studies, in Estonia, 
suggest a high rate of secondary infertility and 
signs of tubal damage were detected at laparo-
scopy in 63-80% of infertile female patients17. After 
an absence of many decades, 17 cases of congenital 
syphilis have been reported since 199310. 
The WHO syndromic management guidelines 
opine that, apart from gonococcal and chlamydial 
infections, it is not necessary to treat other causes of 
urethral discharge such as Ureaplasma urealyticum or 
T. vaginalis. This is because neither are supposed to 
be common and they do not lead to complications18. 
Nevertheless, high rates of trichomonal infection 
have been found in developing countries19'27 and in 
industrialized countries20,28. Recently published 
findings suggest that, even in industrialized coun­
tries, diagnostic evaluation and empirical treatment 
of older men with non-gonococcal urethritis25, and 
partner management in both sexes should include 
treatment for T. vaginalis7526. In Estonia, tricho­
moniasis and chlamydial infection are the most 
prevalent non-viral STIs and, according to pub­
lished data, this is also the situation in the Russian 
Federation29 and in Mongolia20. Unfortunately there 
is scant data from other countries in eastern Europe 
and central Asia, partly because trichomoniasis is 
not a reportable disease in some countries (Latvia 
and Lithuania). In a study of prostitutes in Riga, 
Latvia, of 107 enrolled prostitutes studied, in none 
was evidence of HIV infection detected but the 
prevalences of trichomoniasis, syphilis and gonor­
rhoea among these women were 35.5, 15.7 and 
10.2%, respectively31. 
In men, trichomoniasis has been associated with 
prostatitis, epididymitis and infertility with the 
strongest association being with non-gonococcal 
urethritis. Balanitis and posthitis have been 
described with trichomoniasis and, in severe cases 
penile ulceration too32. In women, vaginitis and 
vulvitis are the main clinical conditions33. Recent 
studies have shown an association between tricho­
moniasis and low birth rate babies (independent 
of HIV infection and other risk factors associated 
with low birth rate)21,34 and preterm labour34. 
Classic STIs may facilitate HIV transmission both 
ways—increasing the infectiousness of and suscept­
ibility to HIV infection35. Degradation of secretory 
leucocyte protease inhibitors (SLPI) is associated 
with trichomonal infection. SLPI is believed to limit 
the transmission of HIV infection by inhibiting 
virus entry into monocytes (in vitro)36. Urethral 
infection with gonorrhoea and trichomoniasis has 
been found to have a significant effect on HIV-1 RNA 
excretion35,37'38. Data from Laga and her colleagues 
show an association between trichomoniasis and 
acquisition of HIV infection in women, with 
estimated relative risks ranging from 1.8-3.022. 
Trichomoniasis is the most common non-viral 
STI worldwide39 and, although often asymptomatic 
in men, it may be more common than is generally 
believed and may persist in the genital tract over a 
long period of time. Although there is information 
that trichomoniasis may play a role in increasing 
HIV transmission, further studies to clarify this will 
be needed. 
Algorithms for the management of urethral 
discharge in men have been evaluated and have 
been proven to be valid and sensitive9 but, with a 
caveat: that the chosen antimicrobial regimens 
should cover the major pathogens responsible for 
the syndromes in a specific region7. By ignoring 
trichomoniasis as a cause of urethritis in men in a 
setting where trichomonal prevalence is high, 
basic syndromic management targets might be 
missed: firstly, effective treatment of the genital 
tract at the first visit and patient satisfaction6-9. 
The first visit may be the only opportunity to treat 
and counsel, as follow-up rates in men can be low6. 
The role of metronidazole as a first-line medication 
in the syndromic management of STIs has been 
discussed by other authors23-40. Researchers in 
southern Thailand have agreed that, in their region, 
T. vaginalis was not common enough to include it 
in a first-line syndromic management protocol for 
male urethritis (prevalence l.f&o)23. However, in 
Estonia, trichomoniasis accounts for 35% of cases 
of male urethritis10 and is found in 59% of men 
with mixed STIs (in a situation where co-infection 
with C. trachomatis and N. gonorrhoeae is detected 
in less than 1% of patients with STIs). Thus it 
might be reasonable to include metronidazole 
among the first-line treatments for the urethral 
discharge syndrome in men. 
To control the incidence of STIs it is important 
that services are accessible, acceptable and that 
the treatment prescribed is effective. Because of 
economic difficulties in Estonia, the management 
of STIs and control efforts are limited and a 
specialist service using full laboratory facilities is 
expensive and is really only accessible to urban 
residents near centres with laboratory support or to 
the minority who can afford to pay for the services. 
Under the Soviet era, the healthcare system was 
centralized, with STI care being mostly provided 
through dermatovenereology clinics which used a 
laboratory-based system of diagnosis. After inde­
pendence in Estonia, while the centralization of 
services is less, it may be appropriate, outside the 
main centres, to provide care for STIs within the 
primary healthcare system1. Certainly, in Estonia, it 
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is perfectly legal to provide STI care at that level 
but doctors practising in that situation often do not 
have adequate training nor access to appropriate 
laboratory facilities and, therefore, accurate diag­
nosis may not always be made—a situation 
described by other authors41. In Tartu, almost all 
gonorrhoea and syphilis cases are reported from 
the University Clinic but, bearing in mind that 
many infections are asymptomatic, and the lack of 
expertise among other doctors (family doctors, 
gynaecologists and urologists), the opportunity is 
probably being lost to treat symptomatic patients 
or, the diagnosis may be completely overlooked. 
We feel that, in the primary care setting there 
would be considerable advantage to the use of 
syndromic STI management protocols and, in 
Estonia, the inclusion of metronidazole amongst 
the medications used for the urethral discharge 
syndrome would be appropriate. 
Acknowledgement: Parts of the information pro­
vided herein were presented at the XIII Meeting of 
the International Society for Sexually Transmitted 
Diseases Research, Denver, Colorado, July 1999. 
References 
1 Waugh MA. Task force for the urgent response to the 
epidemics of sexually transmitted diseases in eastern 
Europe and central Asia. Int ] STD AIDS 1999;10:60-2 
2 Tichonova L, Borisenko K, Ward H, Meheus A, Gromyko 
A, Renton A. Epidemics of syphilis in the Russian 
Federation: trends, origins, and priorities for control. 
Lancet 1997;350:210-13 
3 Adler M. Strategies for prevention and treatment of sexually 
transmitted infections. Int J STD AIDS 1998;9(suppl. 1):&-10 
4 Uusküla A, Silm H, Vessin T. Sexually transmitted diseases 
in Estonia: past and present. Int J STD AIDS 1997;8:446-50 
5 Bingham JS, Waugh MA. Sexually transmitted infections in 
the Russian Federation, the Baltic States and Poland. Int J 
STD AIDS 1999;10:657-8 
6 Dallabeta GA, Gerbase AC, Holmes KK. Problems, solutions, 
and challenges in syndromic management of sexually 
transmitted infections. Sex Transm Inf1998;74(suppl. 1):S1—Sil 
7 Gerbase AC, Rowley JT, Mertens TE. Global epidemiology 
of sexually transmitted diseases. Lancet 1998;351(suppl. 
III):2—4 
8 Wasserheit J. The significance and scope of reproductive 
tract infections among Third World women. Int J Gynecol 
Obstet 1989;3(suppl.):145-68 
9 Sexually Transmitted Diseases: Policies and Principles for 
Prevention and Care. UNA1DS/97.6 
10 National Board of Health Protection. Communicable Diseases 
Statistics in Estonia 1998:24,26,30,61 
11 Szirko F. Prevention of a neonatal infection. Proceedings of 
the 2nd Conference of the Estonian Union Against Sexually 
Transmitted Infections, 9-10 June 2000, Otepää, Estonia 
12 Kibur M, Koskela P, Diliner J, el al. Seropositivity to 
multiple STIs is not common. Sex Transm Dis 2000;27:425-30 
13 Tammai L, Ustina V, Raukas M. Ülevaade eestis registreer­
itud HIV-nakkustest aastatel 1988-1997. Eesti Arst 
1998;suppi. 1:547-50 
14 Archive of Estonian Health Protection Inspectorate and 
HIV/AIDS reference laboratory, Hospital Merimetsa in 
Tallinn, 27 December 2000 
15 Dehne KL, Khodakevich L, Hamers FF, Schwartlander B. 
The HIV/AIDS epidemic in eastern Europe: recent patterns 
and trends and their implications for policy-making. AIDS 
1999;13:741-9 
16 Szirko F. Emakaväline rasedus suguhaiguste esinemissage­
duse indikaatorina. Proceedings of the 1st Conference of 
Estonian Union Against Sexually Transmitted Infections, 11-
12 June 1999, Roosta, Estonia. 
17 Saarma I. Chlamydia trachomatis ja naise infertiilsus. Proceed­
ings of the 2nd Conference of the Estonian Union Against Sexually 
Transmitted Infections, 9-10 June 2000, Otepää, Estonia. 
18 STD Case Management. WHO/GPA/TCO/PMT/95,18 B 
19 Wawer MJ. McNairn D, Wabwire-Managen F, Paxton L, 
Gray RH, Kiwanuka N. Self-administered vaginal swabs for 
population-based assessment of Trichomonas vaginalis pre­
valence. Lancet 1995;345:130-1 
20 Sorvillo F, Kovacs A, Kerndt P, Stek A, Muderspach L, 
Sanchez-Keeland L. Risk factors for trichomoniasis among 
women with human immunodeficiency virus (HIV) at a 
public clinic in Los Angeles County, California: implications 
for HIV prevention. Am / Trop Med Hyg 1998;4:495-500 
21 Sutton MY, Sternberg M, Nsuami M, Behets F, Nelson AM, 
Sr Louis ME. Trichomoniasis in pregnant human immuno­
deficiency virus-infected and human immunodeficiency 
virus-uninfected Congolese women; prevalence, risk factors, 
and association with low birth weight. Am J Obstet Gynecol 
1999;3:656-65 
22 Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative 
sexually transmitted diseases as risk factors for HIV-1 
transmission in women: result from a cohort study. AIDS 
1993;1:95-102 
23 Chandeying V, Skov S, Tabrizi SN, Kemapunmanus M, 
Garland S. Can a two-glass urine test or leucocyte esterase 
test of first-void urine improve syndromic management of 
male urethritis in southern Thailand? Int J STD AIDS 
2000;11:235-40 
24 Sorvillo F, Kerndt P. Trichomonas vaginalis and amplification 
of HIV-1 transmission. Lancet 1998;351:213-14 
25 Joyner JL, Douglas JM Jr, Ragsdale S, Foster M, Judson FN. 
Comparative prevalence of infection with Trichomonas 
vaginalis among men attending a sexually transmitted 
diseases clinic. Sex Transm Dis 2000;27:236-40 
26 Niccolai LM, Kopicko JJ, Kassie A, Petros H, Clark RA, 
Kissinger P. Incidence and predictors of reinfection with 
Trichomonas vaginalis in HIV-infected women. Sex Transm 
Dis 2000;27:284-8 
27 Passey M, Mgone CS, Lupiwa S, et al. Community based 
study of sexually transmitted diseases in rural women in 
the highlands of Papua New Guinea: prevalence and risk 
factors. Sex Transm Dis 1998;2:120-7 
28 Shuter J, Bell D, Graham D, Holbrook KA, Beilin EY. 
Rates of and risk factors for trichomoniasis among 
pregnant inmates in New York City. Sex Transm Dis 
1998;6:303-7 
29 Borisenko KK, Tichonova LI, Renton AM. Syphilis and 
other sexually transmitted infections in the Russian 
Federation. Int J STD AIDS 1990;1:665-8 
30 Purevdawa E, Moon TD, Baigalmaa C, Davaajav K, Smith 
ML, Vermund SH. Rise in sexually transmitted diseases 
during democratization and economic crisis in Mongolia. 
Int I STD AIDS 1997;8:398-401 
31 Kurova T, Shoubnikova M, Malceva A, Mardh PA. 
Prostitution in Riga, Latvia—a socio-medical matter of 
concern. Acta Obstet Gynecol Scand 1998;1:83-6 
32 Kreiger JN. Trichomoniasis in men: old issues and new 
data. Sex Transm Dis 1995;2:83-95 
33 Wolner-Hanssen P, Krieger JN, Stevens CE, et al. Clinical 
manifestations of vaginal trichomoniasis. JAMA 1989;4:571-6 
22 
498 International Journal of STD & AIDS Volume 12 August 2001 
34 Cotch MF, Pastorek JG, Nugent RP, et al. Trichomonas 
vaginalis associated with low birth weight and preterm 
delivery. Sex Transm Dis 1997;6:353-60 
35 Cohen MS. Sexually transmitted diseases enhance HTV 
transmission: no longer a hypothesis. Lancet 1998;suppl. 
ffl:5Sffl-7Sin 
36 Draper D, Donohoe W, Mortimer L, Heine RP. Cysteine 
proteases of Trichomonas vaginalis degrade secretory leuco­
cyte protease inhibitor. / Infect Dis 1998;3:815-19 
37 Cohen MS, Hoffman IF, Royce RA, et al. Reduction of 
concentration of HIV-1 in semen after treatment of 
urethritis: implications for prevention of sexual transmis­
sion of HIV-1. Lancet 1997;349:1868-73 
38 Hobbs MM, Kazembe P, Reed AW, et al. Trichomonas 
vaginalis as a cause of urethritis in Malawian men. Sex 
Transm Dis 1999;7:388-9 
39 WHO/Global Programme on AIDS. Global Prevalence and 
Incidence of Selected Curable Sexually Transmitted Diseases: 
Overview and Estimates. WHO/GPA/STD/95 
40 Jackson DJ, Rakwar JP, Bwayo JJ, Kreiss JK, Moses S. 
Urethral Trichomonas vaginalis infection and HIV-1 transmis­
sion. Lancet 1997^50:1076 
41 Iskandar MB, Patte JH, Qomariyah SN, Vickers C, 
Molyneaux SI. Detecting cervical infection among family 
planning clients: difficulties at the primary health-care level 
in Indonesia. Int / STD AIDS 2000;11:180-6 
(Accepted 25 February 2001) 

Uusküla A, Kaliko va N, Zilmer K, Tammai L, DeHovitz J. 
The role of injecting drug use in the emergence of HIV in Estonia. 
International Journal of Infectious Diseases 2002; 6: (accepted for publication) 
THE ROLE OF INJECTING DRUG USE IN THE EMERGENCE 
OF HIV IN ESTONIA 
Anneli Uusküla\ Nelli Kalikova2 Kai Zilmer3, Lea Tammai, Jack DeHovitz4 
Clinic of Dermatovenerology, University of Tartu, Estonia 
2 AIDS Prevention Center, Tallinn, Estonia 
3Hospital Merimetsa, Tallinn, Estonia 
4 State University of New York, Downstate Medical Center, Brooklyn, NewYork, USA 
Human immunodeficiency virus (HIV) and sexually transmitted disease (STD) epidem­
ics have had remarkable social, demographic and economic consequences in Africa and 
Asia. More recently there has been a dramatic increase in the reported STD incidence in 
East-Europe and Central Asia1. Despite the underreporting of cases and a decline in 
mass screening, an epidemic has been documented2,3. Besides a rise in the STD 
incidence, increasing rates of HIV/AIDS, especially in the Russian Federation, have 
been reported2. 
Injecting drug use is only one of several risks promoting the spread of HIV in 
Europe. Indeed, several countries in West-Europe have reported declining HIV inci­
dences among the drug users during the last decade4. In contrast, the dramatic increase 
in HIV incidence in the countries in East- Europe and in the Russian Federation can be 
attributed primarily to injection drug use5'6. 
In the countries in East-Europe, economic distress, market reforms and political 
restructuring has had a radical impact on everyday life, as well as a negative impact on 
the health care system3,7. These conditions make the communities in those countries 
particularly vulnerable to out-breaks of STDs and HIV8'9. 
This article reviews the marked increase in HIV infection among injecting drug 
users (IDU) in Estonia, a former Soviet Union republic bordering the Baltic Sea. 
Background and methods 
Estonia is a country in East Europe on the shores of the Baltic Sea, which was a Soviet 
republic until it regained its independent statehood in 1991. Estonia is the smallest of 
the three Baltic Republics, covering an area of approximately 45,215 square kilometers 
with a population of approximately 1.4 million people, of whom more than two thirds 
live in urban areas. Administratively, Estonia is divided into 15 counties, the smallest 
with the population of approximately 12,000 and the largest of 535,000. The 2nd largest, 
Ida-Virumaa county (population 193,610 as of 01.01.2000) is located at the North-
Eastern border with the Russian Federation; the county's administrative center Narva 
(population 73,831) is a cross-border town. 
During the first ten years of independence, a decrease in agricultural and industrial 
production occurred, and the economy became more oriented towards provision of 
services. The role of industrial production declined from 39% to 31% in 1991-1995, 
and then it became stabilized. Approximately 6% of Gross Domestic Product (GDP) is 
spent on health care 10. The two main sources of finance for health care provision in 
23 
Estonia are the health insurance system and the state budget. The public health 
insurance embraces about 90% of the Estonian population; it is based on residency, not 
citizenship. 
Basic general statistical data show that the health of Estonians has been deteriorating 
since 1990; the death rates due to cardiovascular diseases, accidents and poisonings 
have all risen. In 1994 life expectancy was lowest, being for men 61.1 years and for 
women 73.1, the former having declined from 66.5 and the latter from 74.9 in 198811. 
However some signs of improvement have been noted in recent years. The infant 
mortality rate that was 15.8 per 1000 live births in 1993 (having been as low as 12.4 in 
1990) has fallen to an all time low of 9,5 in 199911. 
HIV testing was introduced in Estonia in 1987; by now over 2 million HIV tests 
have been performed. In the early years of HIV testing in Estonia, the categories of 
population to be HIV tested were; blood donors (765,442 tests) and pregnant women 
(318,330 tests), and the so-called category of "prophylactic HIV testing" subjects 
(600,370 tests). These included hospital in-patients, and staff in certain occupations 
(food providers, kindergarten staff, etc)as well testing on persons request. The total 
number of HIV tests also include the tests made for medical indications (119,118 tests). 
The tests for medical indications and the tests made for above mentioned transmission 
categories (blood donors, pregnant women, patient request, prophylactic testing) consti­
tute 90% of all the tests performed. The remaining ten per cent of tests made on the 
subjects grouped under other transmission categories (Table l)12. A total number of 
tests performed per year was the highest in 1990 (269,749 tests). The number fell to 
about 80,000 tests per year by 1997, because of changes in the screening policy. Today 
HIV testing is obligatory only for blood donors; pregnant women and prison inmates are 
routinely checked for HIV infection as well. For HIV testing ELISA kits (Abbott, USA; 
Ortho Clinical Diagnostics, USA; BioRad, France) are uniformly used and the results 
verified by the immuno-blot method (Ortho Clinical Diagnostics, USA; BioRad, 
France; Innogenetics, Belgium). 
In Estonia, surveillance of HIV infection and STDs is based on the mandatory universal 
notification of newly identified cases to the State Health Protection Service (with the 
same reporting principles in use throughout the last decades). 
By legal regulations every sample sent for HIV testing has to be coded (on the 
testing form) to identify the transmission category it belongs to. 
Results 
The incidence of syphilis and gonorrea increased substantially during the early 1990s 
and then it began to decline (Figure l)3'13. In contrast, there has been an increase in the 
rate of hepatitis B (17,5/100.000 in 1996 and 34,1/100.000 in 1998) and hepatitis C 
(6,2/100.000 in 1996 and 25,3/100.000 in 1998) in recent years13 (Figure 1). 
To date since 1987, 1305 cases of HIV have reported in Estonia (male/female ratio 
of 914 /255)14'15. The incidence of HIV infections remained very low until recently, 
even when a considerable rise occurred in the incidence of sexually transmitted 
diseases, especially syphilis. Through 1999, only 96 cases of HIV had been reported 
nationally. Since then however, a dramatic increase has occurred: 357 new HIV positive 
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cases were reported during the last 4 months of the year 2000, and an additional 
819 cases during the first 6 months of 2001 (Figure 1). The available data on the 
transmission categories of HIV testing identified groups at risk, including STD patients, 
sailors, and the sexual contacts of HIV-positive persons12,16. Now, according to the data 
of 2000, injecting drug users (IDU) have emerged as group at risk (Table l)12'14'15'17. 
As stipulated by legal regulations, every sample sent for HIV testing has to be coded 
(on the testing form) to identify the transmission category of the sample12. Before 1999, 
only one out of 96 HIV+ cases was categorized as an illegal drug user. According to 
data from testing forms in 2000, 265 (68%) out of 390 HIV + tested persons were 
identified as illegal drug users12. More than one transmission category code can be 
indicated. The illegal drug use category was mostly combined with the "prisoners" or" 
anonymous testing" transmission categories12 (Table 1). The cumulative data, including 
the information recorded on HIV testing forms 12 and clinical records15,17 suggest that 
IDU was a factor in nearly 90% of the new HIV cases reported in year 2000. 
Of now, the majority of new HIV+ cases (797 (74%)/1037) in the years of 2000 and 
2001 are residents in the North-East of Estonia12,14,15'17. 
Discussion 
HIV infection associated with injecting drug use has been reported worldwide, and is 
established as the major cause of rapidly increased rates of HIV infection in several 
countries throughout East-Europe5,6,18. In the newly independent states of the former 
Soviet Union Republics large-scale HIV epidemics have been observed from 1995 
onward, after IDU communities became infected19. 
In Estonia a substantial increase of IDU began in 1994, and it is still on the increase. 
According to the Estonian Health Statistics the number of patients admitted for care for 
psychiatric and behavioral disorders caused by the use of illegal drugs has more than 
tripled during the late 1990s (24.5 / 100000 in 1995, 82.2 / 100 000 in 1998)31. Only ten 
years ago, procurement of illegal narcotic substances in Estonia was difficult if not 
impossible. Older people, whose substance abuse pattern has already been established 
based on consumption of alcohol, do not usually reorient themselves to new substances. 
In 1999, Estonia carried out the European School Survey Project on Alcohol and Other 
Drugs (ESPAD), According to these results, the share of students who have experi­
mented with drugs is almost equal in Tallinn and the towns of Ida-Virumaa county. 
Nevertheless, in Tallinn, narcotic substance use tends to remain within the limits of 
recreational consumption and club life (rave drugs, amphetamines), but in Ida-Virumaa 
county the most popular drugs are opiates. In Estonia there are no great ethnic 
differences related to alcoholism. Even so, among the drug addicts admitted for 
treatment in 2000 there were 83.2% Russians and 11.3% Estonians31. According to the 
data from the same database (drug addicts treatment database) IDU was reported by 
83.4% of drug addicts, and 84% were living either in Tallinn or in Ida-Virumaa 
county20. Unfortunately, no verified data on the extent of drug abuse are available, but 
the number of IDUs in Estonia is estimated to be 10,000-12,000; the majority are 
Russian-speaking (90%) males, aged 15-25 (85%) heroin addicts15,20,21. The marked 
increase in HIV incidence in Estonia was preceded with an increase in the numbers of 
registered cases of hepatitis B and hepatitis C13, likely related to the spread of injecting 
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1 S OO drug use in Estonia ' ' . The increase may also have been caused by a change in the 
pattern of drug use15, from smoking to injecting drugs. The affected patients are young: 
in the1994 to 1997 period there has been an almost five-fold increase in the absolute 
numbers of the registered new cases of hepatitis B and C in the age group 15-19; 50% 
of hepatitis B and 52% of hepatitis C cases were diagnosed in this age group in year 
1997 . 
A study from Estonia by Priimägi and co-workers showed that of the 57 IDUs under 
study, serological markers of hepatitis B were detected in 79% and of hepatitis C in 
83% of the cases22. The incidence of reported new cases of hepatitis B and C is the 
highest in the North-East of Estonia and in Tallinn (the capital city)25. While in the year 
2000 the incidence of hepatitis B was 30.1 and hepatitis C was 20.1 per 100.000 for the 
whole Estonia, in the Ida Virumaa county in the North East it was 122.8 and 76.4, and 
in Tallinn 41.7 and 40.7 accordingly13. These two regions are also known to have the 
worst illegal drug problems in Estonia. 
Social and economic factors are important in the development of risk environments 
conducive to HIV and epidemic spread . An growing admission of the role of social and 
economic factors in STD and HIV spread is subject of the STDs prevention strategies 
which place a great emphasis on the social and structural interventions that require joint 
efforts from the health sector and other community resources26. Economic distress is 
known to be accompanied by an increase of poverty and unemployment. The employ­
ment in Estonia decreased by 23% in 1989-1998, according to labor market studies. As 
segmentary territorial labor division was the rule during the Soviet period in Estonia's 
history, social problems are different in different parts of Estonia. Unemployment is a 
great problem in the Ida-Virumaa county because of the high concentration of the 
former centrally controlled Soviet enterprises in that county27. The inhabitants in the 
Ida-Virumaa county (bordering on Russia) mostly work in those branches of economy 
(e.g. machine-building and metalworking), which have reduced their production 
following the restoration of Estonia's independence, since they cannot use the same 
capacities of raw material or marketing opportunities they had been offered in the 
Soviet Union. The so-called "underground" economies, including those associated with 
crime, and drugs have grown as they can draw their labor force from among the 
unemployed and poor. As shown by the official statistical data, crime was highest in 
Narva and its vicinity crime was also high in Tallinn, the capital of the Republic of 
Estonia 28. Free migration and mixing of people is probably one of the key factors in 
HIV infection outbreaks. Major motorways may serve as conduits for illegal drug 
trafficking. Drugs are known to have a potential of altering sexual mixing patterns 29. 
Narva is located on the route of transport from Russia to Estonia not far from St 
Petersburg. Importantly, Russian Federation also has reported a hundred-fold increase 
in the number of new HIV cases over 1996-1998, with most cases diagnosed in the 
large urban centers of Moscow and St Petersburg7. While in the year 1998, the 
incidence of syphilis for the whole territory of Estonia was 75.7 per 100 000 of 
population, the syphilis incidence (258.8 per 100 000 population) in Narva was much of 
the same magnitude as the syphilis incidence in the Russian Federation in 1998 (234 per 
100 000 population)13'30. 
One of the interesting observations from the last decade of the 20th century in 
Estonia is that the number of HIV infection cases initially remained relatively low, 
despite to the rapidly and substantially increasing STD rates (syphilis in particular) 
4 
(Figure 1). HIV epidemic began to develop only after it was introduced to the drug 
injecting community 
HIV infection appeared in Estonia much later than in many other parts of the world, so 
the experience from other countries that have confronted with the challenges of HIV 
could be of great help and importance for Estonia. The IDU related HIV infection epi­
demic in Estonia emphasizes an urgent need for preventive measures for IDUs as the 
target group. These measures may include syringe needle exchange and distribution 
programs, substitution pharmacotherapy, condom distribution, outreach to IDUs, peer 
education programs. Failure to act now will result in an even more dramatic and 
widespread HIV epidemic in Estonia. 
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Abstract 
Introduction: Since the 1990s, the countries in Eastern Europe and the former republics of the 
Soviet Union have experienced major changes in their political, economic and legal systems 
during the post-communist transformation period. Following the collapse of the Soviet regime, 
there has been a dramatic increase in the reported incidence of sexually transmitted diseases 
(STD). The models of social ecology describe the interrelationship between individuals and 
environment. The factors of sociophysical environment associated with the STD community rates 
are geographic, structural, technological and sociocultural. 
Aim: to study the community-level associations and the incidence rate of syphilis in Estonia 
during the post-communist transition period. 
Methods: We selected the years 1991, 1994 and 1999 to represent the post-communist transition 
period, and studied five sociodemographic characteristics (the percentage of non-ethnic Estonians 
in the population, the percentage of urban population, the rate of homicides, the unemployment 
rate, the number of live births per 1000 females) and the tuberculosis incidence rate. The 
correlation and regression coefficients, and the explained variance values were estimated by the 
ordinary least square regression method. 
Results: Statistically significant relationships were discovered between the syphilis incidence rate 
and the percentage of non-ethnic Estonians in the population (Pearson's r= 0.509), the percentage 
of urban population (Pearson's r= 0.524), the tuberculosis incidence (Pearson's r= 0.444) and the 
birth rate (Pearson's r= -0.501). Statistically significant associations between the syphilis 
incidence rate and the homicides rate (Pearson's r= -0.308), and unemployment rate (Pearson's r= 
-0.022) were not identified. This ecological analysis of the unique situation characterized by the 
radical changes in the community in a very limited time period is a clear illustration of the 
importance of environmental ties for community syphilis (an example of a sexually transmitted 
disease). Our findings emphasize the importance of considering the close relationships between 
health care sector and other community resources in the process of developing strategies to 
prevent sexually transmitted infections. 
Key words: syphilis, Estonia, socioeconomic factors, birth rate, urban 
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Introduction 
Since the 1990s, the countries in Eastern Europe and the former republics of the Soviet 
Union have experienced major changes in their political, economic and legal systems 
during the post-communist transformation period. Following the collapse of the Soviet 
regime, there has been a dramatic increase in the reported incidence of sexually 
transmitted diseases (STD) in Eastern Europe and Central Asia. Although a number of 
cases have escaped reporting, and the mass screening is on the decline, an STD 
epidemic has been documented 1'2'3. 
Estonia, a country in Eastern Europe, and one of the three Baltic States, was a part 
of the Soviet Union until it regained its independent statehood in 1991. In Estonia, STD 
surveillance is conducted by the physicians who notify the Health Protection Inspector­
ate of the new cases diagnosed. The reporting principles of STDs have remained 
unchanged for the decades. 
During and after World War II, a dramatic increase in the incidence of syphilis 
occurred. The total number of new cases in 1949 was 1642 (149/100.000)5. Since then 
the incidence of syphilis started to decrease after the migration and the economical 
situation in the USSR had stabilized, and penicillin was introduced for treatment. The 
disease control and partner notification system became more effective in the same 
period. In Estonia, the annual incidence of new cases of syphilis remained stable 
(< 7/100.000) from 1959 to 1970 2'5. A new increase of syphilis occurred and reached 
the highest levels in 1976 (42/100.000) 5. Whether it was a marker of changed sexual 
behavior (delayed "sexual revolution") or a consequence of intense national policy of 
forced migration within the USSR, remains unclear. The Soviet health care system 
reacted to the increase with relatively repressive measures of partner notification 
combined with compulsory treatment, and as a result, the incidence of syphilis 
decreased again to 8/100.000 in 1982 5. The available data on the last 30 years indicate 
that the ratio of male to female new cases of syphilis has been very constant, never 
exceeding 2:1 2'5. 
The incidence of STDs (syphilis, gonorrhea, chlamydiosis, trichomoniasis) in­
creased rapidly and substantially during the first years of independence from the Soviet 
Union and started to decline after 1994 2'4'5; so the syphilis incidence rate per 100,000 of 
population was 7.4, 75.7 and 41.6 in 1991, 1998 and 2000 respectively. Similar decline 
in the STD incidence has been observed not only in Estonia, but also in the neighboring 
countries 6. 
The health factors on the individual level are biological and psychological-behav­
ioral. The focus in this study was on the latter and their association with the syphilis 
incidence rates. The factors of sociophysical environment associated with the STD 
community rates are geographic (urban areas, proximity to major motorways), structural 
and technological (availability of treatment services and provision of treatment, number 
of physicians, disease prevention programs, STD outreach programs), sociocultural and 
economic (nationality/race relations, mean income, rate of violent crime, unemployment 
rate, birth rate), and prevalence of disease in the population 8'9'10. The awareness of the 
importance of secondary factors beside individual level ones and the impact of those 
factors on the morbidity rate in communities is growing. This notion provides new 
opportunities for STD prevention by conditioning a more fruitful co-operation between 
the health care sector and the other community resources 11,12 The models of social 
ecology describe the interrelationship between individuals and environment. 
2 
The origins of public health and public order overlap to a great extent and they are 
embedded in the security and stability of personal, domestic and community networks 
and other institutions. Disruption of such networks will lead to the increase of violence, 
sexuality, substance abuse and general criminality 13'27. Socially disruptive situation is a 
critical and unique environmental condition that may trigger syphilis epidemic 15. In 
addition to STDs, social disintegration has demonstrated to exacerbate epidemics of 
several other infectious diseases including tuberculosis 29. Population downturn (includ­
ing decrease in birth rates) is an additional phenomenon to coincide with radical 
changes in political, economic and social conditions 18. 
Aim 
This study focused on analyzing the community-level associations and the incidence 
rate of syphilis in Estonia during the post-communist transition period. 
Material and Methods 
Periods of post-Communist transition 
The post-communist transition in Estonia has been divided into the following periods. 
I. 1987-1991 — Liberation movements and political breakthrough. 
II. 1991-1994 — Restoration of the independent statehood involving radical political 
reforms. 
III. 1995 - present — Emergence of a stable democratic system, economic and cultural 
stabilization. 
For the samples of the statistical analysis, the data of the years 1991 (the final year of 
period I), 1994 (the final year of period II), and 1999 (the last reported year of period 
III) were selected. 
Syphilis 
The data on syphilis incidence were taken from the national syphilis case surveillance 
register; syphilis cases are reported to the County Health Protection Bureaus, which 
send monthly reports to the Health Protection Inspectorate. The county syphilis rates 
were calculated with the Statistical Office of Estonia population count estimates (1991— 
1999) as the population denominator for the percentages and rates. 
Sociodemography of counties 
The data used in the analysis were provided by the Statistical Office of Estonia. 
Administratively, Estonia is divided into 15 counties, the smallest has the population of 
approximately 12,000 and the largest of 535,000. The available sociodemographic 
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characteristics of the counties were reviewed, and possible markers of socially 
disruptive situation; unemployment as a new phenomenon in post-communist countries; 
two basic demographic variables, and the tuberculosis incidence rate per 100,000 were 
selected for more detailed analysis. These characteristics were; 
(1) percentage of the non-ethnic Estonians in the population 
(2) percentage of urban population 
(3) rate of homicides per 100,000 
(4) unemployment rate per 100 
(5) number of live births per 1000 females at age 15-^19 
Methods 
The regression coefficients and the explained variance values were estimated by the 
ordinary least square regression. A five per cent significance level was chosen for the 
p-value of the regression coefficient. Pearson's correlation coefficients were calculated. 
Results 
Changes in syphilis occurrence and sociodemographic characteristics 
(Table 1, Figure 2, a-c) 
Syphilis incidence increased from 7.4 per 100,000 in the first period (1990) to 58.4 per 
100,000 in the third period (Table 1). Syphilis is focally distributed in Estonia; there are 
striking local differences in the STD incidence rates. The counties of Põlvamaa and 
Hiiumaa report low syphilis incident rates (5.6/100,000 and 8.4/100,000 respectively), 
but this can partly be attributed to poor syphilis registration in these counties, as there 
are no STD physicians in Põlvamaa and Hiiumaa. The two counties of the highest STD 
rates are; Tallinn, the capital of the Republic of Estonia and Narva, the 3rd largest city 
situated in the North-East of Estonia, near Estonia's border with the Russian Federation 
(Figure 1, Figure 2a). 
The ethnic composition of the population of Estonia has been stable in the past 
decade. Ethnic Estonians comprise about two thirds of the total population. There are 
two regions where the proportion of the non-ethnic Estonians in the population is 
considerably higher than in other places in Estonia: in Tallinn, the capital of the 
Republic of Estonia, non-ethnic Estonians make up nearly 50 per cent and in the Ida-
Virumaa County (in the North East of Estonia) 72 per cent of the population. During the 
1990s, the proportion of urban (-70%) and rural (-30%) population in Estonia was 
stable (Figure 2c). 
The number of live births continuously decreased in Estonia during the period under 
observation. The decrease was more rapid in the first half of the 1990s. The decline in 
fertility slowed down in 1993, and a rise in the birth rate began in 1999. 
A clear trend can be observed when studying the data on homicides in Estonia in the 
1990s. The number of homicides began to grow at the beginning of the decade. In first 
period, the homicide rate was more than 8.7 per 100,000. The worst year was 1994, 
4 
with 365 homicides, a rate of 24.4. In the third period, the rate of homicide was less 
than 14 per 100,000. The areas of the highest crime levels were Tallinn, Narva and Ida-
Virumaa county. 
Unemployment was virtually non-existent during the years of socialism. After the 
collapse of the Soviet Union, unemployment rose during the first and the second period, 
and increased further due to the impact of the Russian economic crisis in the third 
period, to 12.8% (Table 1, Figure 2b). 
The incidence of tuberculosis rose from 21.5 per 100,000 in the first period to 42.3 
per 100,000 in the third period. The majority of the infected were men (approximately 
70%), and the age group 35-55 was the most affected (Figure 2a). 
Association of syphilis with sociodemographic characteristics 
Statistically significant positive correlation was found between syphilis incidence rate 
and percentage of non-Estonian population (Pearson's r= 0.509), urban population 
(Pearson's r= 0.524), and tuberculosis incidence (Pearson's r= 0.444), which explains 
25.9 %, 27.5 %, and 19.7 % of the variation in the syphilis incidence rates across the 
counties and the three time periods, respectively (Table 2). A statistically significant 
negative correlation was also found for syphilis incidence rate and the birth rate 
(Pearson's r= -0.501), which explains 25% of the variance. 
No associations between the syphilis incidence rate, homicides rate, and 
unemployment rate were found (Figure 3, a-f). 
Discussion 
Social disintegration has proven to exacerbate epidemics of infectious diseases, 
including AIDS, and tuberculosis, and such behavioral pathologies as substance abuse 
and violence 13. Especially in case of STDs, societal factors tend to influence risk 
behavior, and consequently the probability of being infected. First, society provides the 
context in which behaviors are shaped and conducted. We observed the reported 
syphilis incidence rate in Estonia during the period of great changes in the society — a 
shift from being a Soviet socialist republic to an independent country with a new 
developing market economy. 
On the basis of the character and scope of societal changes (Lauristin et al}A), the 
transitional process in Estonia can be divided into three following stages. Stage I: 1987-
1991; "The breakthrough'. Strong political mobilization and the rebirth of civil society, 
the beginning of a rapid economic decline and hyperinflation characterize this period of 
liberation movements and political breakthrough. Stage II: 1991-1994; Change takes 
hold'. This period after the restitution of the independent statehood was characterized 
by radical political (the constitutional reform, the institutionalization of the multi-party 
system) reforms. In the field of economy "shock therapy" was applied in line with the 
currency reform, privatization, the rebirth of the independent banking system, 
decreasing inflation, first bankruptcies, rapidly growing consumption. That was a period 
of rapid social differentiation: poor-rich opposition became significant, regional 
differences in the standard of living increased, unemployment slowly grew but was not 
5 
yet a big issue. Stage III: from 1995 onwards; 'Emergence of a stable democratic 
system'. Economy and banking system stabilized and inflation. Estonia's policymakers 
aimed at integration with the European Union and the North Atlantic Treaty Organiza­
tion. Syphilis is a classical example of a STD. Remarkably, syphilis is apparently the 
most consistently reported STD in Estonia 16. During the 1990s, we observed eight-fold 
increase, from 7,4 to 56,6 per 100,000, in syphilis rate between I and II stages. The 
difference between II and III period was 1.1 fold only, from 56,6 to 58,4 per 100,000. 
The incidence of other reported bacterial STD (gonorrhea, chlamydiosis) started to 
decline already in 1994-1995 2'4'5, the trend toward stabilization and decline in the 
incidence of syphilis is apparent from 1999 4'5. Decline in STDs incidences have been 
attributed to a variety of different factors. It has been interpreted to reflect that the peak 
values have been achieved among those socially disadvantaged and at risk. The decline 
is also associated with the changes in care seeking patterns, incomplete case reporting 
due to prescribing symptomatic treatment without the verification of the causative 
agent, and the thorough alterations in the health care system as such 1'2'7. This reversal 
of the trend may also be explained by the introduction of new and potent medicines, 
(e.g. quinolones and cephalosporines in the treatment of gonorrhea), treatment sched­
ules (WHO treatment guidelines and syndromic management principles), but also a 
socio-financial stabilization in the community could be considered 2 In Estonia, the 
period of economical and cultural stabilization and slow growth in living standard 
began in 1995 14. Any type of relational placement in society greatly affects how the 
environment, the individual and the behavioral options are experienced by the 
individual: i.e. individuals who live in poverty perceive the same society and behavioral 
options differently from those with high income. In addition, individuals who have 
means to make decisions experience their society more positively and their behavioral 
options are less dependent on the opinion of others. In our study we constantly 
identified the highest syphilis incidence rates in Ida-Virumaa (Figure 1), region with a 
high percentage of non-ethnic Estonian population and unemployment rate. Syphilis 
rate was positively associated with proportion of non-Estonians (Pearson's r=0.509), but 
we found almost no association with unemployment rate. The ethnic origin is not 
considered a biological risk factor for syphilis; ethnicity is probably a marker of 
interrelationships of ethnicity with other socioeconomic and demographic factors. Due 
to the language-based labor division during the Soviet period, changes in society 
influenced Estonians and non-ethnic Estonians in different ways. The Russian-speaking 
population is largely working in those branches of the economy, which have 
deteriorated after the restoration of Estonia's independence deepening the problem of 
unemployment, furthermore, it is complicated for the non-Estonians residing in Ida-
Virumaa county (Northeast Estonia) to seek work outside their home county because of 
language barriers 16. 
The theories on STD transmission have drawn the readers' attention to the impor-
32 25 26 tance of current prevalence of infection in population , and to social networks * . 
Major motorways may serve as conduits for illegal drug trafficking. Drugs are known to 
have a potential of altering sexual mixing patterns 22. Sexual behavior on travel might 
contribute to STD rates according to a recent Estonian case-control study on sexual 
beliefs and behaviors determining the STD occurrence patters 23. The capital city of Ida-
Virumaa county, Narva, is located on a cross-border motorway between Estonia and the 
Russian Federation, connecting Tallinn with St Petersburg. This area has extremely high 
STD rates (especially syphilis). For example, in 1998, the incidence of syphilis in 
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Estonia was 75.7 per 100,000 population on average, but in Narva, it was 258.8 per 
100,000 population 4'5 which is comparable to the syphilis incidence rate in the Russian 
Federation (234 per 100,000 population) 24. 
Large population downturn subsequent to radical socioeconomic changes during the 
transition period is also noted in the context of other Eastern European countries 1?. The 
rate of live birth is considered to be a marker of social integration; in our study birth rate 
was inversely associated with county syphilis rate (Pearson's r= -0.501. The Estonians 
have higher total fertility rate than non-Estonians, but the declining trend and the slight 
increase in 1999 was similar in both groups. The share of legitimate birth is continu­
ously falling, and the mean age of women at child birth and the mean age of women at 
the birth of the first child were steadily increasing during the 1990s 19. 
The high incidence rate of syphilis was observed in Tallinn, the capital of Estonia. 
Urban residence has proven to be associated with high syphilis rates 20, although there 
may also be a surveillance artifact, with better access to medical care in urban areas 25 
resulting in higher rates of appropriate diagnosis and reporting syphilis cases. In this 
study, the proportion of urban population in the county was strongly associated with the 
county's syphilis rate (Pearson's r= 0.524). Age specific migration rates revealed that 
the growth of internal migration had mostly taken place on account of the decrease of 
non-registered changes of the place of residence of 15-34 year old males and 
15-29 year-old females19 — the age groups most vulnerable to STD related problems. 
In our study, the homicide rate was not associated with the syphilis rate. The high 
crime rate is primarily observed in Estonia's urban areas which are characterized by 
heterogeneous populations, the highest crime rate was recorded in Tallinn, Narva and 
Ida-Virumaa county. These are also the regions with the highest syphilis rates. The 
homicide rate and the syphilis incidence rate in Estonia have manifested similar trends 
for the last decade. According to the 1994 statistics concerning intentional homicides, 
Estonia occupied the seventh place, two places higher than Russian Federation28. 
We found that syphilis rate was positively associated with the tuberculosis incidence 
rate, which further supports the notion of similar risk factors for these infections, e.g. 
social disintegration. In Estonia the tuberculosis incidence increased during 1990s 30. 
This increase, although not so distinctly, coincided with the syphilis incidence increase 
during in the 1990s. Similarly, a stabilization or even a decrease in the tuberculosis 
incidence rates has been evident from the late 1990s onward. Compared with syphilis 
incidence, the tuberculosis incidence has manifested less substantial regional differ­
ences, with the rates being highest in some rural regions of Estonia (Viljandi, Lääne-
Virumaa, Tartumaa counties). Tuberculosis has been noted as a marker disease of 
extreme poverty 29. Alarmingly, the population most affected by tuberculosis in Estonia 
is prison inmates, with the estimated tuberculosis incidence rate in prisons as high as 
764 per 100,000 30. Tuberculosis infection rate is even more problematic because of the 
fact that multi-resistant Mycobacterium tuberculosis strains — from 9 to 20% of newly 
diagnosed tuberculosis cases are being isolated by diagnosis 31. 
Our study on associations between community level determinants and syphilis 
incidence rate is limited in several ways: we used only available county-level data. 
There is an absence of reliable national level data on sexual behavior and alco­
hol/substance abuse. However, this ecological analysis utilized the unique social and 
political situation with radical changes in community in a very limited period, and 
signified the central associations between community-level indicators and the rate of 
syphilis incidence. The results support the theory of syphilis as a social disease. The 
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incidence of syphilis showed considerable variation across space and time, asserting the 
social pattern of the disease. Several sociodemographic characteristics were signifi­
cantly associated with the syphilis incidence rate: the percentage of non-ethic Estonian 
population, the percentage of urban population, the tuberculosis incidence rate, and the 
birth rate. These results underline the magnitude of the socioeconomic and demographic 
factors, and the complex social dimensions of public health problems. Our findings 
emphasize the importance of establishing close ties between the health care sector and 
the other community resources to prevent sexually transmitted infections. The 
importance of effective measures in STD control is further accentuated in the light of 
the advent of HIV/AIDS epidemic in Estonia. 
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Table 1. Explained variance, correlation and regression coefficient for the association between 
syphilis rate and six sociodemographic characteristics 
Explained Regression p-value of Correlation 
variance coefficient regression 
coefficient 
coefficient 
Non-Estonian 0.2587 0.738 0.000 0.509 
population(percentage) 
Urban population (percentage) 0.2745 0.841 0.000 0.524 
Homicides Rate (per 100,000) 0.0948 
-0.632 0.118 -0.308 
Unemployment rate (percentage) 0.0005 -0.002 0.909 -0.022 
Live births (per 1000 females at 0.2513 -0.012 0.000 -0.501 
age 15-49) 
Tuberculosis incidence rate (per 0.1974 0.009 0.002 0.444 
100,000) 
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Figure 1. Syphilis incidence per 100 000 in countries and selected towns of Estonia, 1991,1994, 
1999 
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Figure 2. Selected sociodemographic factors, 1991-2000. 
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Figure 2a. Incidence of syphilis and tuberculosis in Estonia. 
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Figure 2b. Homicide, unemployment and birth rate in Estonia. 
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Figure 2c. Percentage of non-ethnic Estonian and urban population in Estonia. 
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Figure 3. Association of syphilis incidence rate with a) proportion of non-Estonian b) urban 
proportion c) homicides rate d) unemployment rate e) live birth rate f) incidence of tuberculosis 
0.0 .1 .2 .3 A .5 ,6 ,7 
o.O 
HOMICIDE 
d) 
20 30 40 50 60 70 0 10 20 30 40 50 60 70 
(abbreviations: SYF RATE — syphilis incidence rate, NONEST_R — proportion of non-
Estonian, URB_PROP — urban proportion, HOMICIDE_ — homicides rate, UNEMPLY -
unemployment rate, LIVBIRT — live birth rate, TBC_IR — incidence of tuberculosis). 
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HSV-1 and HSV-2 seroprevalence study in Estonia. 
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